FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Joachim Kalden

Research Profile

Disorders

Chemicals & Drugs

Anatomy

Procedures

Co-author Network

Publications

TOP 3
Thaddaeus Till Wissniowski; Reinhard Voll; Eckhart G Hahn; Joachim R Kalden; Silke Meister; Matthias Ocker
Mucin production determines sensitivity to bortezomib and gemcitabine in pancreatic cancer cells.
Alberto Cauli; Dafna D Gladman; Alessandro Mathieu; Ignazio Olivieri; Giovanni Porru; Paul P Tak; Claudia Sardu; Ilona Ujfalussy; Raffaele Scarpa; Antonio Marchesoni; William J Taylor; Antonio Spadaro; Jose L Fernàndez-Sueiro; Carlo Salvarani; Joachim R Kalden; Ennio Lubrano; Sueli Carneiro; Francesca Desiati; John A Flynn; Salvatore D'Angelo; Alessandra Vacca; Arno W R van Kuijk; Maria Grazia Catanoso; Mathias Gruenke; ROSARIO PELUSO; Wendy J Parsons; Nicola Ferrara; Paolo Contu; Philip S Helliwell; Philip J Mease
Patient global assessment in psoriatic arthritis: a multicenter GRAPPA and OMERACT study.
Paul P Tak; Joachim R Kalden
Advances in rheumatology: new targeted therapeutics.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Joachim Kalden (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Thaddaeus Till Wissniowski; Reinhard Voll; Eckhart G Hahn; Joachim R Kalden; Silke Meister; Matthias Ocker
Mucin production determines sensitivity to bortezomib and gemcitabine in pancreatic cancer cells.
International journal of oncology 2012;40(5):1581-9.
2011: Alberto Cauli; Dafna D Gladman; Alessandro Mathieu; Ignazio Olivieri; Giovanni Porru; Paul P Tak; Claudia Sardu; Ilona Ujfalussy; Raffaele Scarpa; Antonio Marchesoni; William J Taylor; Antonio Spadaro; Jose L Fernàndez-Sueiro; Carlo Salvarani; Joachim R Kalden; Ennio Lubrano; Sueli Carneiro; Francesca Desiati; John A Flynn; Salvatore D'Angelo; Alessandra Vacca; Arno W R van Kuijk; Maria Grazia Catanoso; Mathias Gruenke; ROSARIO PELUSO; Wendy J Parsons; Nicola Ferrara; Paolo Contu; Philip S Helliwell; Philip J Mease
Patient global assessment in psoriatic arthritis: a multicenter GRAPPA and OMERACT study.
The Journal of rheumatology 2011;38(5):898-903.
2011: Paul P Tak; Joachim R Kalden
Advances in rheumatology: new targeted therapeutics.
Arthritis research & therapy 2011;13 Suppl 1():S5.
2011: Joachim R Kalden
Anti-TNF therapy: what have we learned in 12 years?
Arthritis research & therapy 2011;13 Suppl 1():S1.
2011: Anna Christine Slagman; Christopher Bock; Hassan Abdel-Aty; Birgit Vogt; Frank Gebauer; Gunnar Janelt; Franziska Wohlgemuth; Rene Morgenstern; Gülcan Yapici; Astrid Puppe; Diethelm Modersohn; Dörte Mans; Timo Jerichow; Sascha Ott; Rudolf Kunze; Wieland Schrödl; Christina Janko; Martin Hermann; Joachim R Kalden; Peter Kern; Hans Parsch; Michael Kirschfink; Jeanette Schulz-Menger; Rainer Röttgen; Juliane K Unger; Ulrich Frei; Ralf Schindler; Martin Möckel; Ahmed Sheriff
Specific removal of C-reactive protein by apheresis in a porcine cardiac infarction model.
Blood purification 2011;31(1-3):9-17.
2009: Luis E Muñoz; Christina Janko; Gerhard E Grossmayer; Benjamin Frey; Reinhard E Voll; Peter Kern; Joachim R Kalden; Georg Schett; Rainer Fietkau; Martin Herrmann; Udo S Gaipl
Remnants of secondarily necrotic cells fuel inflammation in systemic lupus erythematosus.
Arthritis and rheumatism 2009;60(6):1733-42.
2009: Josef S Smolen; C Han; D M F M van der Heijde; P Emery; Joan M Bathon; Edward Keystone; Ravinder N Maini; Joachim R Kalden; Daniel Aletaha; D Baker; J Han; M Bala; E William St Clair
Radiographic changes in rheumatoid arthritis patients attaining different disease activity states with methotrexate monotherapy and infliximab plus methotrexate: the impacts of remission and tumour necrosis factor blockade.
Annals of the rheumatic diseases 2009;68(6):823-7.
2009: Martina Wollin; Silke Abele; Heiko Bruns; Michael Weyand; Joachim R Kalden; Stephan Ensminger; Bernd M Spriewald
Inhibition of TNF-alpha reduces transplant arteriosclerosis in a murine aortic transplant model.
Transplant international : official journal of the European Society for Organ Transplantation 2009;22(3):342-9.
2009: Rainer H Straub; Joachim R Kalden
Stress of different types increases the proinflammatory load in rheumatoid arthritis.
Arthritis research & therapy 2009;11(3):114.
2008: Vilma Urbonaviciute; Barbara G Fürnrohr; Silke Meister; Luis Munoz; Petra Heyder; Francesco De Marchis; Marco E Bianchi; Carsten Kirschning; Hermann Wagner; angelo manfredi; Joachim R Kalden; Georg Schett; Patrizia Rovere-Querini; Martin Herrmann; Reinhard E Voll
Induction of inflammatory and immune responses by HMGB1-nucleosome complexes: implications for the pathogenesis of SLE.
The Journal of experimental medicine 2008;205(13):3007-18.
2008: G E Grossmayer; Luis E Munoz; C K Weber; Sandra Franz; Reinhard E Voll; Peter M Kern; Joachim R Kalden; Georg Schett; Martin Herrmann; Udo S Gaipl
IgG autoantibodies bound to surfaces of necrotic cells and complement C4 comprise the phagocytosis promoting activity for necrotic cells of systemic lupus erythaematosus sera.
Annals of the rheumatic diseases 2008;67(11):1626-32.
2008: Reinhard E Voll; Vilma Urbonaviciute; Barbara G Fürnrohr; Martin Herrmann; Joachim R Kalden
The role of high-mobility group box 1 protein in the pathogenesis of autoimmune diseases.
Current rheumatology reports 2008;10(5):341-2.
2008: Joachim R Kalden; HG Nüsslein; J Wollenhaupt; Gerd R Burmester; K Krüger; Christian Antoni
Combination treatment with infliximab and leflunomide in patients with active rheumatoid arthritis: safety and efficacy in an open-label clinical trial.
Clinical and experimental rheumatology 2008;26(5):834-40.
2008: A Egon van der Bijl; Ferdinand C Breedveld; Christian Antoni; Joachim R Kalden; Sonja Kary; Gerd R Burmester; Christina Beckmann; Kristina Unnebrink; Hartmut Kupper
An open-label pilot study of the effectiveness of adalimumab in patients with rheumatoid arthritis and previous infliximab treatment: relationship to reasons for failure and anti-infliximab antibody status.
Clinical rheumatology 2008;27(8):1021-8.
2008: Stefan Hagel; Jonathan Jantsch; Ulrich Budde; Joachim R Kalden; Kai-Uwe Eckardt; Roland Veelken
Treatment of acquired thrombotic thrombocytopenic purpura (TTP) with plasma infusion plus rituximab.
Thrombosis and haemostasis 2008;100(1):151-3.
2008: Kirsten Neubert; Silke Meister; Katrin Moser; Florian Weisel; Damian Maseda; Kerstin Amann; Carsten Wiethe; Thomas H Winkler; Joachim R Kalden; Rudolf A Manz; Reinhard E Voll
The proteasome inhibitor bortezomib depletes plasma cells and protects mice with lupus-like disease from nephritis.
Nature medicine 2008;14(7):748-55.
2008: Christian E Antoni; Arthur Kavanaugh; Désirée van der Heijde; Anna Beutler; Gregory Keenan; Bei Zhou; Bruce Kirkham; Zuhre Tutuncu; Gerd R Burmester; Udo Schneider; Daniel E Furst; Jerry Molitor; Edward Keystone; Dafna D Gladman; Bernhard Manger; Siegfried Wassenberg; Ralf Weier; Daniel J Wallace; Michael H Weisman; Joachim R Kalden; Josef S Smolen
Two-year efficacy and safety of infliximab treatment in patients with active psoriatic arthritis: findings of the Infliximab Multinational Psoriatic Arthritis Controlled Trial (IMPACT).
The Journal of rheumatology 2008;35(5):869-76.
2008: Rainer H Straub; Georg Pongratz; Maurizio Cutolo; Carla A Wijbrandts; Dominique Baeten; Martin Fleck; Fabiola Atzeni; Mathias Grunke; Joachim R Kalden; Jürgen Schölmerich; Hanns-Martin Lorenz; Paul P Tak; Piercarlo Sarzi Puttini
Increased cortisol relative to adrenocorticotropic hormone predicts improvement during anti-tumor necrosis factor therapy in rheumatoid arthritis.
Arthritis and rheumatism 2008;58(4):976-84.
2008: Martin A Kriegel; Sabine Adam-Klages; Christoph Gabler; Norbert Blank; Martin Schiller; Christina Scheidig; Joachim R Kalden; Hanns-Martin Lorenz
Anti-HLA-DR-triggered monocytes mediate in vitro T cell anergy.
International immunology 2008;20(4):601-13.
2008: Martin Schiller; Sandra Franz; Petra Heyder; Reinhard E Voll; Udo S Gaipl; Hanns-Martin Lorenz; Joachim R Kalden; Martin Herrmann
Hypothesis: human serum-borne albumin bound lipids promote cellular survival after apoptosis induction by a variety of stimuli.
Apoptosis : an international journal on programmed cell death 2008;13(2):319-28.
2008: Reinhard E Voll; Vilma Urbonaviciute; Martin Herrmann; Joachim R Kalden
High mobility group box 1 in the pathogenesis of inflammatory and autoimmune diseases.
The Israel Medical Association journal : IMAJ 2008;10(1):26-8.
2007: Astrid Jüngel; Oliver Distler; Ursula Schulze-Horsel; Lars C Huber; Huy Riem Ha; Beat R Simmen; Joachim R Kalden; David S Pisetsky; Steffen Gay; Jörg H W Distler
Microparticles stimulate the synthesis of prostaglandin E(2) via induction of cyclooxygenase 2 and microsomal prostaglandin E synthase 1.
Arthritis and rheumatism 2007;56(11):3564-74.
2007: Norbert Blank; Martin Schiller; Stefan Krienke; Freja Busse; Birgit Schätz; Anthony Ho; Joachim R Kalden; Hanns-Martin Lorenz
Atorvastatin inhibits T cell activation through 3-hydroxy-3-methylglutaryl coenzyme A reductase without decreasing cholesterol synthesis.
Journal of immunology (Baltimore, Md. : 1950) 2007;179(6):3613-21.
2007: Justin A Chen; Silke Meister; Vilma Urbonaviciute; Franz Rödel; Sabine Wilhelm; Joachim R Kalden; Karin Manger; Reinhard E Voll
Sensitive detection of plasma/serum DNA in patients with systemic lupus erythematosus.
Autoimmunity 2007;40(4):307-10.
2007: Ruediger B Mueller; Alla Skapenko; Jörg Wendler; F Schuch; Joachim R Kalden; Hendrik Schulze-Koops
MHC class II expression on myeloid cells inversely correlates with disease progression in early rheumatoid arthritis.
Rheumatology (Oxford, England) 2007;46(6):931-3.
2007: Sandra Franz; Kai Herrmann; B G Fürnrohr; B Führnrohr; Ahmed Sheriff; Benjamin Frey; Udo S Gaipl; Reinhard E Voll; Joachim R Kalden; Hans-Martin Jäck; Martin Herrmann
After shrinkage apoptotic cells expose internal membrane-derived epitopes on their plasma membranes.
Cell death and differentiation 2007;14(4):733-42.
2007: Udo S Gaipl; Luis E Munoz; Gerhard Grossmayer; Kirsten Lauber; Sandra Franz; Kerstin Sarter; Reinhard E Voll; Thomas Winkler; Annegret Kuhn; Joachim R Kalden; Peter Kern; Martin Herrmann
Clearance deficiency and systemic lupus erythematosus (SLE).
Journal of autoimmunity 2007;28(2-3):114-21.
2007: Judith Auer; Markus Bläss; Hendrik Schulze-Koops; Stefan Russwurm; Thomas Nagel; Joachim R Kalden; Martin Röllinghoff; H Ulrich Beuscher
Expression and regulation of CCL18 in synovial fluid neutrophils of patients with rheumatoid arthritis.
Arthritis research & therapy 2007;9(5):R94.
2007: Jürgen Rech; F Fuchs; Stefan Kallert; Axel J Hueber; C Requadt; Bernhard Manger; Joachim R Kalden; K Amann; R Strauss; Hendrik Schulze-Koops
Plasmapheresis therapy in an elderly patient with rapidly progressive Henoch-Schönlein purpura with disseminated organ involvement.
Clinical rheumatology 2007;26(1):112-4.
2006: Axel J Hueber; Jan Leipe; A Schmid; Joachim R Kalden; Hendrik Schulze-Koops; Jürgen Rech
[Superior vena cava syndrome: Catheter association as a rare cause].
Deutsche medizinische Wochenschrift (1946) 2006;131(49):2774-6.
2006: Axel J Hueber; Stefan Kallert; Thomas Aigner; Wolf Rösler; Joachim R Kalden; Hendrik Schulze-Koops; Jürgen Rech
Early detection of Richter's transformation: stable disease with dose-reduced gemcitabine and local radiation.
Onkologie 2006;29(11):526-8.
2006: Axel J Hueber; Jürgen Rech; Stefan Kallert; C Requadt; A Cavallaro; Joachim R Kalden; Hendrik Schulze-Koops
Paraneoplastic syndrome, infection or arthritis: Difficulties in diagnosis.
International journal of clinical practice 2006;60(10):1310-2.
2006: Jaap Fransen; Christian Antoni; Philip J Mease; Wolfgang Uter; A Kavanaugh; Joachim R Kalden; P L C M van Riel
Performance of response criteria for assessing peripheral arthritis in patients with psoriatic arthritis: analysis of data from randomised controlled trials of two tumour necrosis factor inhibitors.
Annals of the rheumatic diseases 2006;65(10):1373-8.
2006: Martin A Kriegel; Theresa Tretter; Norbert Blank; Martin Schiller; Christoph Gabler; Silke Winkler; Joachim R Kalden; Hanns-Martin Lorenz
Interleukin-4 supports interleukin-12-induced proliferation and interferon-gamma secretion in human activated lymphoblasts and T helper type 1 cells.
Immunology 2006;119(1):43-53.
2006: Axel J Hueber; Jan Leipe; Wolf Roesler; Joachim R Kalden; Stefan Kallert; Jürgen Rech
Palifermin as treatment in dose-intense conventional polychemotherapy induced mucositis.
Haematologica 2006;91(8 Suppl):ECR32.
2006: Sandra Franz; Udo S Gaipl; Luis E Munoz; Ahmed Sheriff; Alexandra Beer; Joachim R Kalden; Martin Herrmann
Apoptosis and autoimmunity: when apoptotic cells break their silence.
Current rheumatology reports 2006;8(4):245-7.
2006: Arthur Kavanaugh; Christian Antoni; Dafna Gladman; S Wassenberg; Bei Zhou; Anna Beutler; Gregory F Keenan; G Burmester; D E Furst; Michael H Weisman; Joachim R Kalden; Josef Smolen; Désirée van der Heijde
The Infliximab Multinational Psoriatic Arthritis Controlled Trial (IMPACT): results of radiographic analyses after 1 year.
Annals of the rheumatic diseases 2006;65(8):1038-43.
2006: Iryna Prots; Alla Skapenko; Jörg Wendler; Stefan Mattyasovszky; Clarisse L Yoné; Bernd M Spriewald; Harald Burkhardt; Rolf Rau; Joachim R Kalden; Peter E Lipsky; Hendrik Schulze-Koops
Association of the IL4R single-nucleotide polymorphism I50V with rapidly erosive rheumatoid arthritis.
Arthritis and rheumatism 2006;54(5):1491-500.
2006: Alexandra Ogilvie; Matthias Lüftl; Christian Antoni; Gerold Schuler; Joachim R Kalden; Hanns-Martin Lorenz
Leukocyte infiltration and mRNA expression of IL-20, IL-8 and TNF-R P60 in psoriatic skin is driven by TNF-alpha.
International journal of immunopathology and pharmacology 2006;19(2):271-8.
2006: Karin Manger; Ludwig Wildt; Joachim R Kalden; Bernhard Manger
Prevention of gonadal toxicity and preservation of gonadal function and fertility in young women with systemic lupus erythematosus treated by cyclophosphamide: the PREGO-Study.
Autoimmunity reviews 2006;5(4):269-72.
2006: Jürgen Rech; Axel J Hueber; Stefan Kallert; C Requadt; Joachim R Kalden; Hendrik Schulze-Koops
Immunoadsorption and CD20 antibody treatment in a patient with treatment resistant systemic lupus erythematosus and preterminal renal insufficiency.
Annals of the rheumatic diseases 2006;65(4):552-3.
2006: Sandra Franz; Benjamin Frey; Ahmed Sheriff; Udo S Gaipl; Alexandra Beer; Reinhard E Voll; Joachim R Kalden; Martin Herrmann
Lectins detect changes of the glycosylation status of plasma membrane constituents during late apoptosis.
Cytometry. Part A : the journal of the International Society for Analytical Cytology 2006;69(4):230-9.
2006: Jürgen Rech; Stefan Kallert; Axel J Hueber; C Requadt; Joachim R Kalden; Hendrik Schulze-Koops
Combination of immunoadsorption and CD20 antibody therapy in a patient with mixed connective tissue disease.
Rheumatology (Oxford, England) 2006;45(4):490-1.
2006: Andrea Böttcher; Udo S Gaipl; Barbara G Fürnrohr; Martin Herrmann; Irute Girkontaite; Joachim R Kalden; Reinhard E Voll
Involvement of phosphatidylserine, alphavbeta3, CD14, CD36, and complement C1q in the phagocytosis of primary necrotic lymphocytes by macrophages.
Arthritis and rheumatism 2006;54(3):927-38.
2006: Josef S Smolen; Chenglong Han; Désirée van der Heijde; Paul Emery; Joan M Bathon; Edward Keystone; Joachim R Kalden; Michael Schiff; Mohan Bala; Daniel Baker; John Han; Ravinder N Maini; E William St Clair
Infliximab treatment maintains employability in patients with early rheumatoid arthritis.
Arthritis and rheumatism 2006;54(3):716-22.
2006: Josef S Smolen; Désirée van der Heijde; E William St Clair; Paul Emery; Joan M Bathon; Edward Keystone; Ravinder N Maini; Joachim R Kalden; Michael Schiff; Daniel Baker; Chenglong Han; John Han; Mohan Bala
Predictors of joint damage in patients with early rheumatoid arthritis treated with high-dose methotrexate with or without concomitant infliximab: results from the ASPIRE trial.
Arthritis and rheumatism 2006;54(3):702-10.
2006: Axel J Hueber; Franziska G Matzkies; Martina Rahmeh; Bernhard Manger; Joachim R Kalden; Thomas Nagel
CTLA-4 lacking the cytoplasmic domain costimulates IL-2 production in T-cell hybridomas.
Immunology and cell biology 2006;84(1):51-8.
2006: Udo S Gaipl; Ahmed Sheriff; Sandra Franz; Luis E Munoz; Reinhard E Voll; Joachim R Kalden; Martin Herrmann
Inefficient clearance of dying cells and autoreactivity.
Current topics in microbiology and immunology 2006;305():161-76.
2006: Stefan Mattyasovszky; Alla Skapenko; Joachim R Kalden; Peter E Lipsky; Hendrik Schulze-Koops
IFNGR1 single nucleotide polymorphisms in rheumatoid arthritis.
Arthritis research & therapy 2006;8(3):R63.
2006: Rüdiger Eming; Jürgen Rech; Sandra Barth; Joachim R Kalden; Gerold Schuler; Thomas Harrer; Michael Hertl
Prolonged clinical remission of patients with severe pemphigus upon rapid removal of desmoglein-reactive autoantibodies by immunoadsorption.
Dermatology (Basel, Switzerland) 2006;212(2):177-87.
2006: Udo S Gaipl; A Kuhn; Ahmed Sheriff; Luis E Munoz; Sandra Franz; Reinhard E Voll; Joachim R Kalden; Martin Herrmann
Clearance of apoptotic cells in human SLE.
Current directions in autoimmunity 2006;9():173-87.
2006: Jörg H W Distler; Astrid Jüngel; David Caretto; Ursula Schulze-Horsel; Otylia Kowal-Bielecka; Renate E Gay; Beat A Michel; Ulf Müller-Ladner; Joachim R Kalden; Steffen Gay; Oliver Distler
Monocyte chemoattractant protein 1 released from glycosaminoglycans mediates its profibrotic effects in systemic sclerosis via the release of interleukin-4 from T cells.
Arthritis and rheumatism 2006;54(1):214-25.
2005: Norbert Blank; Martin Schiller; Christoph Gabler; Joachim R Kalden; Hanns-Martin Lorenz
Inhibition of sphingolipid synthesis impairs cellular activation, cytokine production and proliferation in human lymphocytes.
Biochemical pharmacology 2005;71(1-2):126-35.
2005: Judith Schlenk; Hanns-Martin Lorenz; Johannes-Peter Haas; Martin Herrmann; Gerd Hohenberger; Joachim R Kalden; Martin Röllinghoff; H Ulrich Beuscher
Extravasation into synovial tissue induces CCL20 mRNA expression in polymorphonuclear neutrophils of patients with rheumatoid arthritis.
The Journal of rheumatology 2005;32(12):2291-8.
2005: Francis Dodeller; Alla Skapenko; Joachim R Kalden; Peter E Lipsky; Hendrik Schulze-Koops
The p38 mitogen-activated protein kinase regulates effector functions of primary human CD4 T cells.
European journal of immunology 2005;35(12):3631-42.
2005: Jörg H W Distler; David S Pisetsky; Lars C Huber; Joachim R Kalden; Steffen Gay; Oliver Distler
Microparticles as regulators of inflammation: novel players of cellular crosstalk in the rheumatic diseases.
Arthritis and rheumatism 2005;52(11):3337-48.
2005: Alla Skapenko; Joachim R Kalden; Peter E Lipsky; Hendrik Schulze-Koops
The IL-4 receptor alpha-chain-binding cytokines, IL-4 and IL-13, induce forkhead box P3-expressing CD25+CD4+ regulatory T cells from CD25-CD4+ precursors.
Journal of immunology (Baltimore, Md. : 1950) 2005;175(9):6107-16.
2005: Hanns-Martin Lorenz; Mathias Grunke; Jörg Wendler; P A Heinzel; Joachim R Kalden
Safety of 15-deoxyspergualin in the treatment of glomerulonephritis associated with active systemic lupus erythematosus.
Annals of the rheumatic diseases 2005;64(10):1517-9.
2005: Martin Schiller; Norbert Blank; Petra Heyder; Martin Herrmann; Udo S Gaipl; Joachim R Kalden; Hanns-Martin Lorenz
Induction of apoptosis by spermine-metabolites in primary human blood cells and various tumor cell lines.
Apoptosis : an international journal on programmed cell death 2005;10(5):1151-62.
2005: Norbert Blank; Roland Repp; Wolfgang Römer; Joachim R Kalden; Gisela Helm; Thomas Harrer; Hanns-Martin Lorenz; Rolf Janka
Multiple bone lesions of systemic multifocal fibrosclerosis.
AJR. American journal of roentgenology 2005;185(3):668-70.
2005: Luis E Munoz; Udo S Gaipl; Sandra Franz; Ahmed Sheriff; Reinhard E Voll; Joachim R Kalden; Martin Herrmann
SLE--a disease of clearance deficiency?
Rheumatology (Oxford, England) 2005;44(9):1101-7.
2005: Joachim R Kalden; Christian Antoni; Jose M Alvaro-Gracia; Bernard Combe; Paul Emery; Joel M Kremer; C Vibeke Strand; P L C M van Riel; Josef S Smolen
Use of combination of leflunomide with biological agents in treatment of rheumatoid arthritis.
The Journal of rheumatology 2005;32(8):1620-31.
2005: Ute Wellmann; Miriam Letz; Martin Herrmann; Sieglinde Angermüller; Joachim R Kalden; Thomas H Winkler
The evolution of human anti-double-stranded DNA autoantibodies.
Proceedings of the National Academy of Sciences of the United States of America 2005;102(26):9258-63.
2005: Reinhard E Voll; Joachim R Kalden
Do we need new treatment that goes beyond tumor necrosis factor blockers for rheumatoid arthritis?
Annals of the New York Academy of Sciences 2005;1051():799-810.
2005: Harald Burkhardt; Bettina Sehnert; Robert Bockermann; Ake Engström; Joachim R Kalden; Rikard Holmdahl
Humoral immune response to citrullinated collagen type II determinants in early rheumatoid arthritis.
European journal of immunology 2005;35(5):1643-52.
2005: Udo S Gaipl; Reinhard E Voll; Ahmed Sheriff; Sandra Franz; Joachim R Kalden; Martin Herrmann
Impaired clearance of dying cells in systemic lupus erythematosus.
Autoimmunity reviews 2005;4(4):189-94.
2005: Christian Antoni; Arthur Kavanaugh; Bruce Kirkham; Zuhre Tutuncu; Gerd R Burmester; Udo Schneider; Daniel E Furst; Jerry Molitor; Edward Keystone; Dafna Gladman; Bernhard Manger; Siegfried Wassenberg; Ralf Weier; Daniel J Wallace; Michael H Weisman; Joachim R Kalden; Josef Smolen
Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT).
Arthritis and rheumatism 2005;52(4):1227-36.
2005: Josef S Smolen; Chenglong Han; Mohan Bala; Ravinder N Maini; Joachim R Kalden; Désirée van der Heijde; Ferdinand C Breedveld; D E Furst; P E Lipsky
Evidence of radiographic benefit of treatment with infliximab plus methotrexate in rheumatoid arthritis patients who had no clinical improvement: a detailed subanalysis of data from the anti-tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study.
Arthritis and rheumatism 2005;52(4):1020-30.
2005: Vibeke Strand; David Scott; Paul Emery; Joachim R Kalden; Josef S Smolen; Grant W Cannon; Peter Tugwell; Bruce Crawford
Physical function and health related quality of life: analysis of 2-year data from randomized, controlled studies of leflunomide, sulfasalazine, or methotrexate in patients with active rheumatoid arthritis.
The Journal of rheumatology 2005;32(4):590-601.
2005: Wasilis Kolowos; Udo S Gaipl; Ahmed Sheriff; Reinhard E Voll; Petra Heyder; P Kern; Joachim R Kalden; Martin Herrmann
Microparticles shed from different antigen-presenting cells display an individual pattern of surface molecules and a distinct potential of allogeneic T-cell activation.
Scandinavian journal of immunology 2005;61(3):226-33.
2005: Jörg H W Distler; Astrid Jüngel; Otylia Kowal-Bielecka; Beat A Michel; Renate E Gay; Haiko Sprott; Marco Matucci-Cerinic; Meike Chilla; Kristian Reich; Joachim R Kalden; Ulf Müller-Ladner; Hanns M Lorenz; Steffen Gay; Oliver Distler
Expression of interleukin-21 receptor in epidermis from patients with systemic sclerosis.
Arthritis and rheumatism 2005;52(3):856-64.
2005: Bernd M Spriewald; Oliver Witzke; Ralf Wassmuth; René R Wenzel; Marie-Luise Arnold; T Philipp; Joachim R Kalden
Distinct tumour necrosis factor alpha, interferon gamma, interleukin 10, and cytotoxic T cell antigen 4 gene polymorphisms in disease occurrence and end stage renal disease in Wegener's granulomatosis.
Annals of the rheumatic diseases 2005;64(3):457-61.
2005: Ruediger B Mueller; Alla Skapenko; Mathias Grunke; Jörg Wendler; Bruno Stuhlmuller; Joachim R Kalden; Hendrik Schulze-Koops
Regulation of myeloid cell function and major histocompatibility complex class II expression by tumor necrosis factor.
Arthritis and rheumatism 2005;52(2):451-60.
2005: Gerhard E Grossmayer; Luis E Munoz; Udo S Gaipl; Sandra Franz; Ahmed Sheriff; Reinhard E Voll; Joachim R Kalden; Martin Herrmann
Removal of dying cells and systemic lupus erythematosus.
Modern rheumatology / the Japan Rheumatism Association 2005;15(6):383-90.
2005: Jürgen Brunner; Peter M Kern; Udo S Gaipl; Luis E Munoz; Reinhard E Voll; Joachim R Kalden; Craig W Wiesenhutter; Martin Herrmann
The low-throughput protein A adsorber: an immune modulatory device. Hypothesis for the mechanism of action in the treatment of rheumatoid arthritis.
Modern rheumatology / the Japan Rheumatism Association 2005;15(1):9-18.
2005: Ellen G Harrer; Michael Bäuerle; Barbara Ferstl; Paul Chaplin; Barbara Petzold; Luis Mateo; Amanda Handley; Maria Tzatzaris; Jens Vollmar; Silke Bergmann; Marion Rittmaier; Kathrin Eismann; Sandra Müller; Joachim R Kalden; Bernd M Spriewald; Dieter Willbold; Thomas Harrer
Therapeutic vaccination of HIV-1-infected patients on HAART with a recombinant HIV-1 nef-expressing MVA: safety, immunogenicity and influence on viral load during treatment interruption.
Antiviral therapy 2005;10(2):285-300.
2005: Martin A Kriegel; Joachim R Kalden; Hanns-Martin Lorenz
Lambert-Eaton myasthenic syndrome and undifferentiated connective tissue disease in a patient carrying the 8.1 ancestral haplotype.
Annals of the rheumatic diseases 2005;64(1):167-8.
2004: Jörg H W Distler; Joachim R Kalden; S Gray; Oliver Distler
[Vascular changes in the pathogenesis of systemic sclerosis].
Zeitschrift für Rheumatologie 2004;63(6):446-50.
2004: Udo S Gaipl; Sandra Franz; Reinhard E Voll; Ahmed Sheriff; Joachim R Kalden; Martin Herrmann
Defects in the disposal of dying cells lead to autoimmunity.
Current rheumatology reports 2004;6(6):401-7.
2004: Ahmed Sheriff; Udo S Gaipl; Sandra Franz; Petra Heyder; Reinhard E Voll; Joachim R Kalden; Martin Herrmann
Loss of GM1 surface expression precedes annexin V-phycoerythrin binding of neutrophils undergoing spontaneous apoptosis during in vitro aging.
Cytometry. Part A : the journal of the International Society for Analytical Cytology 2004;62(2):75-80.
2004: Andrei Calin; B A C Dijkmans; Paul Emery; M Hakala; Joachim R Kalden; M Leirisalo-Repo; EM Mola; C Salvarani; R Sanmartí; Jacques Sany; J Sibilia; Joachim Sieper; S van der Linden; E Veys; A M Appel; Saeed Fatenejad
Outcomes of a multicentre randomised clinical trial of etanercept to treat ankylosing spondylitis.
Annals of the rheumatic diseases 2004;63(12):1594-600.
2004: Marie-Luise Arnold; Thorsten Zacher; Michael Dechant; Joachim R Kalden; Ilias Doxiadis; Bernd M Spriewald
Detection and specification of noncomplement binding anti-HLA alloantibodies.
Human immunology 2004;65(11):1288-96.
2004: E William St Clair; Désirée van der Heijde; Josef S Smolen; Ravinder N Maini; Joan M Bathon; Paul Emery; Edward Keystone; Michael Schiff; Joachim R Kalden; Ben Wang; Kimberly Dewoody; Roberta Weiss; Daniel Baker
Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trial.
Arthritis and rheumatism 2004;50(11):3432-43.
2004: Attilio Bondanza; Valérie S Zimmermann; Patrizia Rovere-Querini; Javier Turnay; Ingrid E Dumitriu; Christian Stach; Reinhard E Voll; Udo S Gaipl; Wolf Bertling; Ernst Pöschl; Joachim R Kalden; angelo manfredi; Martin Herrmann
Inhibition of phosphatidylserine recognition heightens the immunogenicity of irradiated lymphoma cells in vivo.
The Journal of experimental medicine 2004;200(9):1157-65.
2004: Christoph Gabler; Norbert Blank; Thomas Hieronymus; Martin Schiller; J H M Berden; Joachim R Kalden; Hanns-Martin Lorenz
Extranuclear detection of histones and nucleosomes in activated human lymphoblasts as an early event in apoptosis.
Annals of the rheumatic diseases 2004;63(9):1135-44.
2004: Ahmed Sheriff; Udo S Gaipl; Reinhard E Voll; Joachim R Kalden; Martin Herrmann
Apoptosis and systemic lupus erythematosus.
Rheumatic diseases clinics of North America 2004;30(3):505-27, viii-ix.
2004: Hanns-Martin Lorenz; Joachim R Kalden
Dysregulation of apoptosis as mechanism supporting the induction of autoimmunity.
Current rheumatology reports 2004;6(4):249-51.
2004: Bettina Sehnert; Andrea Cavcic; Beate Böhm; Joachim R Kalden; Kutty Selva Nandakumar; Rikard Holmdahl; Harald Burkhardt
Antileukoproteinase: modulation of neutrophil function and therapeutic effects on anti-type II collagen antibody-induced arthritis.
Arthritis and rheumatism 2004;50(7):2347-59.
2004: Claudia Dechant; P Schauenberg; Christian Antoni; Hans G Kraetsch; Joachim R Kalden; Bernhard Manger
[Longterm outcome of TNF blockade in adult-onset Still's disease].
Deutsche medizinische Wochenschrift (1946) 2004;129(23):1308-12.
2004: Joachim R Kalden; Josef S Smolen; Paul Emery; P L C M van Riel; Maxime Dougados; C Vibeke Strand; Ferdinand C Breedveld
Lefunomide in combination therapy.
The Journal of rheumatology. Supplement 2004;71():25-30.
2004: P L C M van Riel; Josef S Smolen; Paul Emery; Joachim R Kalden; Maxime Dougados; C Vibeke Strand; Ferdinand C Breedveld
Leflunomide: a manageable safety profile.
The Journal of rheumatology. Supplement 2004;71():21-4.
2004: Josef S Smolen; Paul Emery; Joachim R Kalden; P L C M van Riel; Maxime Dougados; C Vibeke Strand; Ferdinand C Breedveld
The efficacy of leflunomide monotherapy in rheumatoid arthritis: towards the goals of disease modifying antirheumatic drug therapy.
The Journal of rheumatology. Supplement 2004;71():13-20.
2004: Alla Skapenko; Gerald U Niedobitek; Joachim R Kalden; Peter E Lipsky; Hendrik Schulze-Koops
Generation and regulation of human Th1-biased immune responses in vivo: a critical role for IL-4 and IL-10.
Journal of immunology (Baltimore, Md. : 1950) 2004;172(10):6427-34.
2004: Martin A Kriegel; Tobias Lohmann; Christoph Gabler; Norbert Blank; Joachim R Kalden; Hanns-Martin Lorenz
Defective suppressor function of human CD4+ CD25+ regulatory T cells in autoimmune polyglandular syndrome type II.
The Journal of experimental medicine 2004;199(9):1285-91.
2004: Karin Manger; Claudia Dechant; Joachim R Kalden; Bernhard Manger
Clinical images: Periarticular inflammation in rapidly developing Jaccoud's arthropathy.
Arthritis and rheumatism 2004;50(5):1700.
2004: Ravinder N Maini; F C Breedveld; Joachim R Kalden; J S Smolen; D Furst; M H Weisman; E William St Clair; Gregory F Keenan; Désirée van der Heijde; PA Marsters; P E Lipsky
Sustained improvement over two years in physical function, structural damage, and signs and symptoms among patients with rheumatoid arthritis treated with infliximab and methotrexate.
Arthritis and rheumatism 2004;50(4):1051-65.
2004: Ingrid E Dumitriu; Reinhard E Voll; Wasilis Kolowos; Udo S Gaipl; Petra Heyder; Joachim R Kalden; Martin Herrmann
UV irradiation inhibits ABC transporters via generation of ADP-ribose by concerted action of poly(ADP-ribose) polymerase-1 and glycohydrolase.
Cell death and differentiation 2004;11(3):314-20.
2004: Lars Klareskog; Désirée van der Heijde; Julien P de Jager; Andrew Gough; Joachim R Kalden; Michel Malaise; Emilio Martín-Mola; Karel Pavelka; Jacques Sany; Lucas Settas; Joseph Wajdula; Ronald Pedersen; Saeed Fatenejad; Marie Sanda
Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial.
Lancet 2004;363(9410):675-81.
2004: Alla Skapenko; Jan Leipe; Uwe Niesner; koenraad devriendt; Rolf Beetz; Andreas Radbruch; Joachim R Kalden; Peter E Lipsky; Hendrik Schulze-Koops
GATA-3 in human T cell helper type 2 development.
The Journal of experimental medicine 2004;199(3):423-8.
2004: Udo S Gaipl; Thomas D Beyer; Petra Heyder; Susanne Kuenkele; Andrea Böttcher; Reinhard E Voll; Joachim R Kalden; Martin Herrmann
Cooperation between C1q and DNase I in the clearance of necrotic cell-derived chromatin.
Arthritis and rheumatism 2004;50(2):640-9.
2004: Jörg H W Distler; Claudia Hagen; Astrid Hirth; Ulf Müller-Ladner; Hanns M Lorenz; Angela Del Rosso; Beat A Michel; Renate E Gay; Ratanavadee Nanagara; Kusuki Nishioka; Marco Matucci-Cerinic; Joachim R Kalden; Steffen Gay; Oliver Distler
Bucillamine induces the synthesis of vascular endothelial growth factor dose-dependently in systemic sclerosis fibroblasts via nuclear factor-kappaB and simian virus 40 promoter factor 1 pathways.
Molecular pharmacology 2004;65(2):389-99.
2003: Roland Repp; Heidi H van Ojik; Thomas Valerius; Gerard Groenewegen; G Wieland; C Oetzel; Bernhard Stockmeyer; W Becker; M Eisenhut; H Steininger; YM Deo; Geert H Blijham; Joachim R Kalden; Jan G J van de Winkel; Martin Gramatzki
Phase I clinical trial of the bispecific antibody MDX-H210 (anti-FcgammaRI x anti-HER-2/neu) in combination with Filgrastim (G-CSF) for treatment of advanced breast cancer.
British journal of cancer 2003;89(12):2234-43.
2003: Christoph Gabler; Norbert Blank; Silke Winkler; Joachim R Kalden; Hanns-Martin Lorenz
Accumulation of histones in cell lysates precedes expression of apoptosis-related phagocytosis signals in human lymphoblasts.
Annals of the New York Academy of Sciences 2003;1010():221-4.
2003: L B A Van De Putte; Rolf Rau; F C Breedveld; Joachim R Kalden; Michel Malaise; P L C M van Riel; Manfred Schattenkirchner; P Emery; Gerd R Burmester; H Zeidler; H M Moutsopoulos; K Beck; Hartmut Kupper
Efficacy and safety of the fully human anti-tumour necrosis factor alpha monoclonal antibody adalimumab (D2E7) in DMARD refractory patients with rheumatoid arthritis: a 12 week, phase II study.
Annals of the rheumatic diseases 2003;62(12):1168-77.
2003: Bernhard Stockmeyer; Thomas Beyer; Winfried Neuhuber; Roland Repp; Joachim R Kalden; Thomas Valerius; Martin Herrmann
Polymorphonuclear granulocytes induce antibody-dependent apoptosis in human breast cancer cells.
Journal of immunology (Baltimore, Md. : 1950) 2003;171(10):5124-9.
2003: Marvin Fritzler; Allan Wiik; Eng M Tan; Josef S Smolen; J Steven McDougal; Edward Chan; Thomas P Gordon; John Hardin; Joachim R Kalden; Robert G Lahita; Ravinder N Maini; Westley H Reeves; Naomi F Rothfield; Yoshinari Takasaki; Merlin Wilson; Martha G Byrd; Lloyd Slivka; James A Koziol
A critical evaluation of enzyme immunoassay kits for detection of antinuclear autoantibodies of defined specificities. III. Comparative performance characteristics of academic and manufacturers' laboratories.
The Journal of rheumatology 2003;30(11):2374-81.
2003: Christoph Gabler; Joachim R Kalden; Hanns-Martin Lorenz
The putative role of apoptosis-modified histones for the induction of autoimmunity in Systemic Lupus Erythematosus.
Biochemical pharmacology 2003;66(8):1441-6.
2003: Petra Heyder; Udo S Gaipl; Thomas D Beyer; Reinhard E Voll; Peter M Kern; Christian Stach; Joachim R Kalden; Martin Herrmann
Early detection of apoptosis by staining of acid-treated apoptotic cells with FITC-labeled lectin from Narcissus pseudonarcissus.
Cytometry. Part A : the journal of the International Society for Analytical Cytology 2003;55(2):86-93.
2003: Karin Manger; Magda Kusus; C Forster; Dieter Ropers; Werner G Daniel; Joachim R Kalden; Stephan Achenbach; Bernhard Manger
Factors associated with coronary artery calcification in young female patients with SLE.
Annals of the rheumatic diseases 2003;62(9):846-50.
2003: Ingrid E Dumitriu; Franz Roedel; Thomas D Beyer; Udo S Gaipl; Joachim R Kalden; Martin Herrmann
UV or X-irradiation increases the cytoplasmic accumulation of rhodamine 123 in various cancer cell lines.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2003;179(8):564-70.
2003: Martin A Kriegel; Ulrike Hüffmeier; Elisabeth Scherb; Christina Scheidig; Thomas Geiler; Joachim R Kalden; André Reis; Hanns-Martin Lorenz
Tumor necrosis factor receptor-associated periodic syndrome characterized by a mutation affecting the cleavage site of the receptor: implications for pathogenesis.
Arthritis and rheumatism 2003;48(8):2386-8.
2003: Joachim R Kalden; M Schattenkirchner; H Sörensen; Paul Emery; C Deighton; B Rozman; Ferdinand C Breedveld
The efficacy and safety of leflunomide in patients with active rheumatoid arthritis: a five-year followup study.
Arthritis and rheumatism 2003;48(6):1513-20.
2003: Rainer H Straub; Georg Pongratz; Jürgen Schölmerich; Frieder Kees; Thomas F Schaible; Christian Antoni; Joachim R Kalden; Hanns-Martin Lorenz
Long-term anti-tumor necrosis factor antibody therapy in rheumatoid arthritis patients sensitizes the pituitary gland and favors adrenal androgen secretion.
Arthritis and rheumatism 2003;48(6):1504-12.
2003: Susanne Kuenkele; Thomas D Beyer; Reinhard E Voll; Joachim R Kalden; Martin Herrmann
Impaired clearance of apoptotic cells in systemic lupus erythematosus: challenge of T and B cell tolerance.
Current rheumatology reports 2003;5(3):175-7.
2003: Ulf Wagner; Sylke Kaltenhäuser; Matthias Pierer; Wolfram Seidel; Michael Tröltzsch; Holm Häntzschel; Joachim R Kalden; R Wassmuth
Prospective analysis of the impact of HLA-DR and -DQ on joint destruction in recent-onset rheumatoid arthritis.
Rheumatology (Oxford, England) 2003;42(4):553-62.
2003: Josef S Smolen; F C Breedveld; M H Schiff; Joachim R Kalden; P Emery; Gabriele J M Eberl; P L van Riel; P Tugwell
A simplified disease activity index for rheumatoid arthritis for use in clinical practice.
Rheumatology (Oxford, England) 2003;42(2):244-57.
2003: Rainer Birck; Klaus Warnatz; Hanns-Martin Lorenz; Mira Choi; Marion Haubitz; Mathias Grünke; Hans-Hartmut Peter; Joachim R Kalden; Ursula Göbel; Johannes M Drexler; Osamu Hotta; Rainer Nowack; Fokko J van der Woude
15-Deoxyspergualin in patients with refractory ANCA-associated systemic vasculitis: a six-month open-label trial to evaluate safety and efficacy.
Journal of the American Society of Nephrology : JASN 2003;14(2):440-7.
2003: Udo S Gaipl; Thomas D Beyer; Irith Baumann; Reinhard E Voll; Christian Stach; Petra Heyder; Joachim R Kalden; angelo manfredi; Martin Herrmann
Exposure of anionic phospholipids serves as anti-inflammatory and immunosuppressive signal--implications for antiphospholipid syndrome and systemic lupus erythematosus.
Immunobiology 2003;207(1):73-81.
2003: Udo S Gaipl; Jürgen Brunner; Thomas D Beyer; Reinhard E Voll; Joachim R Kalden; Martin Herrmann
Disposal of dying cells: a balancing act between infection and autoimmunity.
Arthritis and rheumatism 2003;48(1):6-11.
2003: F G Matzkies; Bernhard Manger; Matthias Schmitt-Haendle; Thomas Nagel; Hans G Kraetsch; Joachim R Kalden; Hendrik Schulze-Koops
Severe septicaemia in a patient with polychondritis and Sweet's syndrome after initiation of treatment with infliximab.
Annals of the rheumatic diseases 2003;62(1):81-2.
2002: Norbert Blank; Christoph Gabler; Martin Schiller; Martin A Kriegel; Joachim R Kalden; Hanns-Martin Lorenz
A fast, simple and sensitive method for the detection and quantification of detergent-resistant membranes.
Journal of immunological methods 2002;271(1-2):25-35.
2002: Karin Manger; Bernhard Manger; Roland Repp; M Geisselbrecht; A Geiger; A Pfahlberg; Thomas Harrer; Joachim R Kalden
Definition of risk factors for death, end stage renal disease, and thromboembolic events in a monocentric cohort of 338 patients with systemic lupus erythematosus.
Annals of the rheumatic diseases 2002;61(12):1065-70.
2002: Joachim R Kalden
Expanding role of biologic agents in rheumatoid arthritis.
The Journal of rheumatology. Supplement 2002;66():27-37.
2002: Christian Antoni; Claudia Dechant; P D Hanns-Martin Lorenz; Jörg Wendler; Alexandra Ogilvie; Mathias Lueftl; Dolores Kalden-Nemeth; Joachim R Kalden; Bernhard Manger
Open-label study of infliximab treatment for psoriatic arthritis: clinical and magnetic resonance imaging measurements of reduction of inflammation.
Arthritis and rheumatism 2002;47(5):506-12.
2002: Thorsten Zacher; Ina Knerr; Wolfgang Rascher; Joachim R Kalden; Ralf Wassmuth
Characterization of monocyte-derived dendritic cells in recent-onset diabetes mellitus type 1.
Clinical immunology (Orlando, Fla.) 2002;105(1):17-24.
2002: Petya Dimitrova; Alla Skapenko; Matthias L Herrmann; Rudolf Schleyerbach; Joachim R Kalden; Hendrik Schulze-Koops
Restriction of de novo pyrimidine biosynthesis inhibits Th1 cell activation and promotes Th2 cell differentiation.
Journal of immunology (Baltimore, Md. : 1950) 2002;169(6):3392-9.
2002: Harald Burkhardt; Tobias Koller; Ake Engström; Kutty Selva Nandakumar; Javier Turnay; Hans G Kraetsch; Joachim R Kalden; Rikard Holmdahl
Epitope-specific recognition of type II collagen by rheumatoid arthritis antibodies is shared with recognition by antibodies that are arthritogenic in collagen-induced arthritis in the mouse.
Arthritis and rheumatism 2002;46(9):2339-48.
2002: Bernhard Stockmeyer; Martin Schiller; Roland Repp; Hanns-Martin Lorenz; Joachim R Kalden; Martin Gramatzki; Thomas Valerius
Enhanced killing of B lymphoma cells by granulocyte colony-stimulating factor-primed effector cells and Hu1D10--a humanized human leucocyte antigen DR antibody.
British journal of haematology 2002;118(4):959-67.
2002: Thomas D Beyer; Wasilis Kolowos; Ingrid E Dumitriu; Reinhard E Voll; Petra Heyder; Udo S Gaipl; Joachim R Kalden; Martin Herrmann
Apoptosis of the teratocarcinoma cell line Tera-1 leads to the cleavage of HERV-K10gag proteins by caspases and/or granzyme B.
Scandinavian journal of immunology 2002;56(3):303-9.
2002: Karin Manger; Roland Repp; M Jansen; M Geisselbrecht; Ralf Wassmuth; N A C Westerdaal; A Pfahlberg; Bernhard Manger; Joachim R Kalden; Jan G J van de Winkel
Fcgamma receptor IIa, IIIa, and IIIb polymorphisms in German patients with systemic lupus erythematosus: association with clinical symptoms.
Annals of the rheumatic diseases 2002;61(9):786-92.
2002: Joachim R Kalden; H Lochs; H Wollheim
[Remicade in therapy of rheumatoid arthritis and Crohn diseases--no reason for panic].
Zeitschrift für Rheumatologie 2002;61(4):466-8.
2002: Norbert Blank; Renate Burger; Birgit Duerr; Frank Bakker; Anika Wohlfarth; Ingrid E Dumitriu; Joachim R Kalden; Martin Herrmann
MEK inhibitor U0126 interferes with immunofluorescence analysis of apoptotic cell death.
Cytometry 2002;48(4):179-84.
2002: Lee S Simon; Josef S Smolen; Steven B Abramson; Gerald Appel; Claire Bombardier; D Craig Brater; Ferdinand C Breedveld; K Brune; Gerd R Burmester; Leslie J Crofford; Maxime Dougados; Raymond DuBois; garret fitzgerald; W Frishman; Luis A García Rodríguez; Marc C Hochberg; Joachim R Kalden; Loren Laine; M J S Langman; Stephen M Prescott; L B A Van De Putte; Andrew Whelton; William B White; Gordon H Willaims
Controversies in COX-2 selective inhibition.
The Journal of rheumatology 2002;29(7):1501-10.
2002: Yehuda Shoenfeld; Yaniv Sherer; Joachim R Kalden
The expanding world of autoimmunity.
Trends in immunology 2002;23(6):278-9.
2002: Hanns-Martin Lorenz; Mathias Grünke; Thomas Hieronymus; Silke Winkler; Norbert Blank; Astrid Rascu; Jörg Wendler; Thomas Geiler; Joachim R Kalden
Hyporesponsiveness to gammac-chain cytokines in activated lymphocytes from patients with systemic lupus erythematosus leads to accelerated apoptosis.
European journal of immunology 2002;32(5):1253-63.
2002: H Stadick; Bernhard Stockmeyer; Reinhard Kühn; Karl M Schrott; Joachim R Kalden; Martin J Glennie; Jan G J van de Winkel; Martin Gramatzki; Thomas Valerius; D Elsässer
Epidermal growth factor receptor and g250: useful target antigens for antibody mediated cellular cytotoxicity against renal cell carcinoma?
The Journal of urology 2002;167(2 Pt 1):707-12.
2002: Joachim R Kalden
Emerging role of anti-tumor necrosis factor therapy in rheumatic diseases.
Arthritis research 2002;4 Suppl 2():S34-40.
2002: Hanns-Martin Lorenz; Joachim R Kalden
Perspectives for TNF-alpha-targeting therapies.
Arthritis research 2002;4 Suppl 3():S17-24.
2002: Eng M Tan; Josef S Smolen; J Steven McDougal; Marvin Fritzler; Thomas Gordon; John Hardin; Joachim R Kalden; Robert G Lahita; Ravinder N Maini; Westley H Reeves; Naomi F Rothfield; Yoshinari Takasaki; Allan Wiik; Merlin Wilson; James A Koziol
A critical evaluation of enzyme immunoassay kits for detection of antinuclear autoantibodies of defined specificities. II. Potential for quantitation of antibody content.
The Journal of rheumatology 2002;29(1):68-74.
2002: Irith Baumann; Wasilis Kolowos; Reinhard E Voll; Bernhard Manger; Udo S Gaipl; Winfried Neuhuber; Thomas Kirchner; Joachim R Kalden; Martin Herrmann
Impaired uptake of apoptotic cells into tingible body macrophages in germinal centers of patients with systemic lupus erythematosus.
Arthritis and rheumatism 2002;46(1):191-201.
2001: Ingrid E Dumitriu; W Mohr; Wasilis Kolowos; P Kern; Joachim R Kalden; Martin Herrmann
5,6-carboxyfluorescein diacetate succinimidyl ester-labeled apoptotic and necrotic as well as detergent-treated cells can be traced in composite cell samples.
Analytical biochemistry 2001;299(2):247-52.
2001: H Schulze-Koops; Joachim R Kalden
The balance of Th1/Th2 cytokines in rheumatoid arthritis.
Best practice & research. Clinical rheumatology 2001;15(5):677-91.
2001: Hans G Kraetsch; Christian Antoni; Joachim R Kalden; Bernhard Manger
Successful treatment of a small cohort of patients with adult onset of Still's disease with infliximab: first experiences.
Annals of the rheumatic diseases 2001;60 Suppl 3():iii55-7.
2001: Hanns-Martin Lorenz; Joachim R Kalden
[New therapy developments in rheumatoid arthritis].
Zeitschrift für Rheumatologie 2001;60(5):326-32.
2001: David Scott; Josef S Smolen; Joachim R Kalden; L B van de Putte; A Larsen; TK Kvien; M Schattenkirchner; P Nash; C Oed; I Loew-Friedrich
Treatment of active rheumatoid arthritis with leflunomide: two year follow up of a double blind, placebo controlled trial versus sulfasalazine.
Annals of the rheumatic diseases 2001;60(10):913-23.
2001: Beate Böhm; Thomas Aigner; Carl P Blobel; Joachim R Kalden; Harald Burkhardt
Highly enhanced expression of the disintegrin metalloproteinase MDC15 (metargidin) in rheumatoid synovial tissue.
Arthritis and rheumatism 2001;44(9):2046-54.
2001: Joachim R Kalden; David Scott; Josef S Smolen; M Schattenkirchner; B Rozman; B D Williams; TK Kvien; P Jones; R B Williams; C Oed; R Rosenburg
Improved functional ability in patients with rheumatoid arthritis--longterm treatment with leflunomide versus sulfasalazine. European Leflunomide Study Group.
The Journal of rheumatology 2001;28(9):1983-91.
2001: H Burkhardt; Joachim R Kalden; H Schulze-Koops
Chicken and egg in autoimmunity and joint inflammation.
Trends in immunology 2001;22(6):291-3.
2001: Joachim R Kalden
How do the biologics fit into the current DMARD armamentarium?
The Journal of rheumatology. Supplement 2001;62():27-35.
2001: Hans G Kraetsch; C Unger; P Wernhoff; C Schneider; Joachim R Kalden; Rikard Holmdahl; Harald Burkhardt
Cartilage-specific autoimmunity in rheumatoid arthritis: characterization of a triple helical B cell epitope in the integrin-binding-domain of collagen type II.
European journal of immunology 2001;31(6):1666-73.
2001: Ralf Wassmuth; Ingeborg A Hauser; K Schuler; H Erxleben; Marie-Luise Arnold; C A Koelman; F H Claas; Joachim R Kalden
Differential inhibitory effects of intravenous immunoglobulin preparations on HLA-alloantibodies in vitro.
Transplantation 2001;71(10):1436-42.
2001: Norbert Blank; Martin A Kriegel; Thomas Hieronymus; Thomas Geiler; Silke Winkler; Joachim R Kalden; Hanns-Martin Lorenz
CD45 tyrosine phosphatase controls common gamma-chain cytokine-mediated STAT and extracellular signal-related kinase phosphorylation in activated human lymphoblasts: inhibition of proliferation without induction of apoptosis.
Journal of immunology (Baltimore, Md. : 1950) 2001;166(10):6034-40.
2001: Jörg Wendler; Thomas Hummel; M Reissinger; Bernhard Manger; Elisabeth Pauli; Joachim R Kalden; Gerd Kobal
Patients with rheumatoid arthritis adapt differently to repetitive painful stimuli compared to healthy controls.
Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 2001;8(3):272-7.
2001: Udo S Gaipl; Susanne Kuenkele; Reinhard E Voll; Thomas D Beyer; Wasilis Kolowos; Petra Heyder; Joachim R Kalden; Martin Herrmann
Complement binding is an early feature of necrotic and a rather late event during apoptotic cell death.
Cell death and differentiation 2001;8(4):327-34.
2001: Alla Skapenko; Peter E Lipsky; Hans G Kraetsch; Joachim R Kalden; Hendrik Schulze-Koops
Antigen-independent Th2 cell differentiation by stimulation of CD28: regulation via IL-4 gene expression and mitogen-activated protein kinase activation.
Journal of immunology (Baltimore, Md. : 1950) 2001;166(7):4283-92.
2001: Alexandra Ogilvie; Christian Antoni; Claudia Dechant; Bernhard Manger; Joachim R Kalden; Gerold Schuler; Matthias Lüftl
Treatment of psoriatic arthritis with antitumour necrosis factor-alpha antibody clears skin lesions of psoriasis resistant to treatment with methotrexate.
The British journal of dermatology 2001;144(3):587-9.
2001: Peter M Kern; Ludwig Keilholz; Joachim R Kalden; Martin Herrmann
Apoptotic UV-irradiated lymphocytes undergo protease mediated shedding of L-selectin in vitro.
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis 2001;24(1):99-101.
2001: Wasilis Kolowos; Udo S Gaipl; Reinhard E Voll; C Frank; Johannes-Peter Haas; Thomas D Beyer; Joachim R Kalden; Martin Herrmann
CD4 positive peripheral T cells from patients with systemic lupus erythematosus (SLE) are clonally expanded.
Lupus 2001;10(5):321-31.
2001: Hanns-Martin Lorenz; Joachim R Kalden
[Cytokines and anti-cytokine therapy in rheumatoid arthritis].
Der Internist 2001;42(1):55-6, 59-63.
2001: A J G Swaak; HG van den Brink; RJ Smeenk; K Manger; Joachim R Kalden; Silvia Tosi; Z Domljan; Blaz Rozman; Dusan Logar; G Pokorny; L Kovacs; A Kovacs; PG Vlachoyiannopoulos; HM Moutsopoulos; H Chwalinska-Sadowska; E Kiss; Nada Cikes; Branimir Anic; M Schneider; R Fischer; S Bombardieri; M Mosca; W Graninger; Josef S Smolen
Systemic lupus erythematosus. Disease outcome in patients with a disease duration of at least 10 years: second evaluation.
Lupus 2001;10(1):51-8.
2001: A J G Swaak; H van de Brink ; RJ Smeenk; K Manger; Joachim R Kalden; Silvia Tosi; Antonio Marchesoni; Z Domljan; Blaz Rozman; Dusan Logar; G Pokorny; L Kovacs; A Kovacs; PG Vlachoyiannopoulos; HM Moutsopoulos; H Chwalinska-Sadowska; B Dratwianka; E Kiss; Nada Cikes; Branimir Anic; M Schneider; R Fischer; S Bombardieri; M Mosca; W Graninger; Josef S Smolen
Incomplete lupus erythematosus: results of a multicentre study under the supervision of the EULAR Standing Committee on International Clinical Studies Including Therapeutic Trials (ESCISIT).
Rheumatology (Oxford, England) 2001;40(1):89-94.
2000: Joachim R Kalden
The application of infliximab (Remicade), a chimeric monoclonal antibody, in the treatment of rheumatic diseases.
The Israel Medical Association journal : IMAJ 2000;2 Suppl():11-2.
2000: Bernhard Stockmeyer; Michael Dechant; Marjolein van Egmond; Alison L Tutt; K Sundarapandiyan; Robert F Graziano; Roland Repp; Joachim R Kalden; Martin Gramatzki; Martin J Glennie; Jan G J van de Winkel; Thomas Valerius
Triggering Fc alpha-receptor I (CD89) recruits neutrophils as effector cells for CD20-directed antibody therapy.
Journal of immunology (Baltimore, Md. : 1950) 2000;165(10):5954-61.
2000: Hanns-Martin Lorenz; Martin Herrmann; T Winkler; Udo S Gaipl; Joachim R Kalden
Role of apoptosis in autoimmunity.
Apoptosis : an international journal on programmed cell death 2000;5(5):443-9.
2000: M Hundt; Karin Manger; T Dörner; B Grimbacher; P Kalden; Astrid Rascu; D Weber; G R Burmester; Hans-Hartmut Peter; Joachim R Kalden; R E Schmidt
Treatment of acute exacerbation of systemic lupus erythematosus with high-dose intravenous immunoglobulin.
Rheumatology (Oxford, England) 2000;39(11):1301-2.
2000: Christian Stach; X Turnay; Reinhard E Voll; Peter M Kern; Wasilis Kolowos; Thomas D Beyer; Joachim R Kalden; Martin Herrmann
Treatment with annexin V increases immunogenicity of apoptotic human T-cells in Balb/c mice.
Cell death and differentiation 2000;7(10):911-5.
2000: Martin Herrmann; T Winkler; Udo S Gaipl; H Lorenz; Thomas Geiler; Joachim R Kalden
Etiopathogenesis of systemic lupus erythematosus.
International archives of allergy and immunology 2000;123(1):28-35.
2000: Thomas Hieronymus; P Grötsch; Norbert Blank; Mathias Grünke; D Capraru; Thomas Geiler; Silke Winkler; Joachim R Kalden; Hanns-Martin Lorenz
Chlorpromazine induces apoptosis in activated human lymphoblasts: a mechanism supporting the induction of drug-induced lupus erythematosus?
Arthritis and rheumatism 2000;43(9):1994-2004.
2000: Peter M Kern; Ludwig Keilholz; C Forster; Christian Stach; Thomas D Beyer; Udo S Gaipl; Joachim R Kalden; Rupert Hallmann; Martin Herrmann
UVB-irradiated T-cells undergoing apoptosis lose L-selectin by metalloprotese-mediated shedding.
International journal of radiation biology 2000;76(9):1265-71.
2000: S Kasten; Andreas Goldwich; Matthias Schmitt; Astrid Rascu; Mathias Grunke; Claudia Dechant; Joachim R Kalden; Thomas Harrer
Positive influence of the Delta32CCR5 allele on response to highly active antiretroviral therapy (HAART) in HIV-1 infected patients.
European journal of medical research 2000;5(8):323-8.
2000: Peter M Kern; Martin Herrmann; Bernhard Stockmeyer; Joachim R Kalden; Thomas Valerius; Roland Repp
Flow cytometric discrimination between viable neutrophils, apoptotic neutrophils and eosinophils by double labelling of permeabilized blood granulocytes.
Journal of immunological methods 2000;241(1-2):11-8.
2000: Thomas Nagel; Joachim R Kalden; Bernhard Manger
Co-stimulation of IL-2 production by CD28 is independent of tyrosine-based signaling motifs in a murine T cell hybridoma.
European journal of immunology 2000;30(6):1632-7.
2000: Thomas Hieronymus; Norbert Blank; M Gruenke; Silke Winkler; Johannes-Peter Haas; Joachim R Kalden; Hanns-Martin Lorenz
CD 95-independent mechanisms of IL-2 deprivation-induced apoptosis in activated human lymphocytes.
Cell death and differentiation 2000;7(6):538-47.
2000: Matthias Schmitt; Ellen G Harrer; Andreas Goldwich; Michael Bäuerle; I Graedner; Joachim R Kalden; Thomas Harrer
Specific recognition of lamivudine-resistant HIV-1 by cytotoxic T lymphocytes.
AIDS (London, England) 2000;14(6):653-8.
2000: P Meyer; Harald Burkhardt; Ernesta Palombo-Kinne; Wilfried Gründer; Rolf Bräuer; KJ Stiller; Joachim R Kalden; Wolfgang Becker; Raimund W Kinne
123I-antileukoproteinase scintigraphy reveals microscopic cartilage alterations in the contralateral knee joint of rats with "monarticular" antigen-induced arthritis.
Arthritis and rheumatism 2000;43(2):298-310.
2000: Hanns-Martin Lorenz; Mathias Grünke; Thomas Hieronymus; Christian Antoni; HG Nüsslein; Thomas F Schaible; Bernhard Manger; Joachim R Kalden
In vivo blockade of tumor necrosis factor-alpha in patients with rheumatoid arthritis: longterm effects after repeated infusion of chimeric monoclonal antibody cA2.
The Journal of rheumatology 2000;27(2):304-10.
2000: Hendrik Schulze-Koops; Joachim R Kalden
Where is biological therapy going?
Arthritis research 2000;2(5):337-41.
2000: P Kern; Joachim R Kalden; Bernhard Manger
Inflammatory arterial stenosis: followup with color Doppler sonography.
Arthritis and rheumatism 2000;43(1):238.
1999: P Kern; Wasilis Kolowos; M Hagenhofer; C Frank; Joachim R Kalden; Martin Herrmann
Alternatively spliced mRNA molecules of the thrombospondin receptor (CD36) in human PBMC.
European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics 1999;26(5):337-42.
1999: A J G Swaak; HG van den Brink; RJ Smeenk; K Manger; Joachim R Kalden; Silvia Tosi; Antonio Marchesoni; Z Domljan; Blaz Rozman; Dusan Logar; G Pokorny; L Kovacs; A Kovacs; PG Vlachoyiannopoulos; HM Moutsopoulos; H Chwalinska-Sadowska; B Dratwianka; E Kiss; Nada Cikes; A Branimir; M Schneider; R Fischer; S Bombardieri; M Mosca; Josef S Smolen
Systemic lupus erythematosus: clinical features in patients with a disease duration of over 10 years, first evaluation.
Rheumatology (Oxford, England) 1999;38(10):953-8.
1999: Beate Böhm; Thomas Aigner; Angelika Gehrsitz; Carl P Blobel; Joachim R Kalden; Harald Burkhardt
Up-regulation of MDC15 (metargidin) messenger RNA in human osteoarthritic cartilage.
Arthritis and rheumatism 1999;42(9):1946-50.
1999: Hanns-Martin Lorenz; Joachim R Kalden
[Cytokines and mediators as therapeutic approaches].
Der Internist 1999;40(9):945-50.
1999: Alla Skapenko; Jörg Wendler; Peter E Lipsky; Joachim R Kalden; Hendrik Schulze-Koops
Altered memory T cell differentiation in patients with early rheumatoid arthritis.
Journal of immunology (Baltimore, Md. : 1950) 1999;163(1):491-9.
1999: Wasilis Kolowos; Matthias Schmitt; M Herrman; Ellen G Harrer; Peter Löw; Joachim R Kalden; Thomas Harrer
Biased TCR repertoire in HIV-1-infected patients due to clonal expansion of HIV-1-reverse transcriptase-specific CTL clones.
Journal of immunology (Baltimore, Md. : 1950) 1999;162(12):7525-33.
1999: R E Voll; A Mikulowska; Joachim R Kalden; R Holmdahl
Amelioration of type II collagen induced arthritis in rats by treatment with sodium diethyldithiocarbamate.
The Journal of rheumatology 1999;26(6):1352-8.
1999: H M Lorenz; Joachim R Kalden
Biologic agents in the treatment of inflammatory rheumatic diseases.
Current opinion in rheumatology 1999;11(3):179-84.
1999: H Schulze-Koops; Harald Burkhardt; Joachim R Kalden
What we have learned from trials of immunomodulatory agents in rheumatoid arthritis: Future directions.
Drugs of today (Barcelona, Spain : 1998) 1999;35(4-5):327-51.
1999: Bernd M Spriewald; Astrid Rascu; Karl Heinz Schaller; Jürgen Angerer; Joachim R Kalden; Thomas Harrer
Lead induced anaemia due to traditional Indian medicine: a case report.
Occupational and environmental medicine 1999;56(4):282-3.
1999: Astrid Rascu; Hans G Kraetsch; Mathias Grünke; Joachim R Kalden; Bernhard Manger
[An unusual case of Heberden arthrosis in a young man].
Zeitschrift für Rheumatologie 1999;58(2):95-9.
1999: Norbert Blank; H Steininger; Joachim R Kalden; Harald Burkhardt
Symptomatic bone lesion of the tibia head as onset manifestation of sarcoidosis.
The Journal of rheumatology 1999;26(4):936-7.
1999: Ralf Wagner; Bernd Leschonsky; Ellen G Harrer; Christina Paulus; C Weber; B D Walker; S Buchbinder; Hans Wolf; Joachim R Kalden; Thomas Harrer
Molecular and functional analysis of a conserved CTL epitope in HIV-1 p24 recognized from a long-term nonprogressor: constraints on immune escape associated with targeting a sequence essential for viral replication.
Journal of immunology (Baltimore, Md. : 1950) 1999;162(6):3727-34.
1999: Saifeddin Alsalameh; K Winter; R al-Ward; Jörg Wendler; Joachim R Kalden; Raimund W Kinne
Distribution of TNF-alpha, TNF-R55 and TNF-R75 in the rheumatoid synovial membrane: TNF receptors are localized preferentially in the lining layer; TNF-alpha is distributed mainly in the vicinity of TNF receptors in the deeper layers.
Scandinavian journal of immunology 1999;49(3):278-85.
1999: Saifeddin Alsalameh; B Mattka; R al-Ward; Hanns-Martin Lorenz; Bernhard Manger; Klaus Pfizenmaier; Matthias Grell; Joachim R Kalden
Preferential expression of tumor necrosis factor receptor 55 (TNF-R55) on human articular chondrocytes: selective transcriptional upregulation of TNF-R75 by proinflammatory cytokines interleukin 1beta, tumor necrosis factor-alpha, and basis fibroblast growth factor.
The Journal of rheumatology 1999;26(3):645-53.
1999: Eng M Tan; Josef S Smolen; J S McDougal; BT Butcher; D Conn; R Dawkins; Marvin Fritzler; T Gordon; John Hardin; Joachim R Kalden; Robert G Lahita; Ravinder N Maini; Naomi F Rothfield; RJ Smeenk; Y Takasaki; Walther J van Venrooij; Allan Wiik; M Wilson; J A Koziol
A critical evaluation of enzyme immunoassays for detection of antinuclear autoantibodies of defined specificities. I. Precision, sensitivity, and specificity.
Arthritis and rheumatism 1999;42(3):455-64.
1999: S Landgraf; Claudia Dechant; Bernhard Manger; Joachim R Kalden
[Lyme borreliosis: current status of diagnosis and therapy].
Medizinische Klinik (Munich, Germany : 1983) 1999;94(2):105-8.
1999: Josef S Smolen; Joachim R Kalden; David Scott; B Rozman; TK Kvien; A Larsen; I Loew-Friedrich; C Oed; R Rosenburg
Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial. European Leflunomide Study Group.
Lancet 1999;353(9149):259-66.
1999: Joachim R Kalden
Changing the course of rheumatoid arthritis. Introduction.
Scandinavian journal of rheumatology. Supplement 1999;112():1.
1998: Martin Gramatzki; W D Ludwig; R Burger; P Moos; Peter Rohwer; C Grünert; A Sendler; Joachim R Kalden; R Andreesen; F Henschke; G Moldenhauer
Antibodies TC-12 ("unique") and TH-111 (CD96) characterize T-cell acute lymphoblastic leukemia and a subgroup of acute myeloid leukemia.
Experimental hematology 1998;26(13):1209-14.
1998: Thomas Harrer; J Schwab; Wilhelm G. Struff; M Schmitt; J H Ficker; W Rödl; H Parsch; Joachim R Kalden; Martin Gramatzki
Intralymphatic interleukin-2 in combination with zidovudine for the therapy of patients with AIDS.
Infection 1998;26(6):368-74.
1998: Thomas Harrer; Ellen G Harrer; P Barbosa; F Kaufmann; Ralf Wagner; S Brüggemann; Joachim R Kalden; Mark B Feinberg; R P Johnson; S Buchbinder; B D Walker
Recognition of two overlapping CTL epitopes in HIV-1 p17 by CTL from a long-term nonprogressing HIV-1-infected individual.
Journal of immunology (Baltimore, Md. : 1950) 1998;161(9):4875-81.
1998: Thomas Nagel; Joachim R Kalden; Bernhard Manger
[Regulation of T-cell activation by CD28 and CTLA-4].
Medizinische Klinik (Munich, Germany : 1983) 1998;93(10):592-7.
1998: Peter Löw; Frank Neipel; Astrid Rascu; H Steininger; Bernhard Manger; Bernhard Fleckenstein; Joachim R Kalden; Thomas Harrer
Suppression of HHV-8 viremia by foscarnet in an HIV-infected patient with Kaposi's sarcoma and HHV-8 associated hemophagocytic syndrome.
European journal of medical research 1998;3(10):461-4.
1998: Ravinder N Maini; F C Breedveld; Joachim R Kalden; J S Smolen; D Davis; J D Macfarlane; Christian Antoni; Burkhard F Leeb; MJ Elliott; Jim Woody; Thomas F Schaible; Eugene Eyo Akujuru
Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis.
Arthritis and rheumatism 1998;41(9):1552-63.
1998: Raimund W Kinne; P Meyer; Wilfried Gründer; Eberhard Buchner; Ernesta Palombo-Kinne; R Heinzel-Wieland; Wolfgang Becker; F Wolf; Joachim R Kalden; Harald Burkhardt
Rat antigen-induced arthritis: cartilage alterations assessed with iodine-123-antileukoproteinase.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1998;39(9):1638-45.
1998: Hanns-Martin Lorenz; A S Lagoo; S A Lagoo-Deenadalayan; W H Barber; Joachim R Kalden; K J Hardy
Epitope-specific signaling through CD45 on T lymphocytes leads to cAMP synthesis in monocytes after ICAM-1-dependent cellular interaction.
European journal of immunology 1998;28(8):2300-10.
1998: D Würflein; Michael Dechant; Bernhard Stockmeyer; Alison L Tutt; P Hu; Roland Repp; Joachim R Kalden; Jan G J van de Winkel; A L Epstein; Thomas Valerius; Martin J Glennie; Martin Gramatzki
Evaluating antibodies for their capacity to induce cell-mediated lysis of malignant B cells.
Cancer research 1998;58(14):3051-8.
1998: Bernd M Spriewald; Ralf Wassmuth; Hans-Dieter Carl; Ferdinand Köckerling; Sandra Reichstetter; A Kleeberger; M Klein; M W Hohenberger; Joachim R Kalden
Microchimerism after liver transplantation: prevalence and methodological aspects of detection.
Transplantation 1998;66(1):77-83.
1998: Martin Herrmann; M Neidhart; Steffen Gay; M Hagenhofer; Joachim R Kalden
Retrovirus-associated rheumatic syndromes.
Current opinion in rheumatology 1998;10(4):347-54.
1998: Mathias Grunke; Hans G Kraetsch; Peter Löw; Astrid Rascu; Joachim R Kalden; Thomas Harrer
Nelfinavir associated with peripheral neuropathy in an HIV-infected patient.
Infection 1998;26(4):252.
1998: Wolf Rösler; B Manger; R Repp; Joachim R Kalden; Martin Gramatzki
Autologous PBPCT in a patient with lymphoma and Sjögren's syndrome: complete remission of lymphoma without control of the autoimmune disease.
Bone marrow transplantation 1998;22(2):211-3.
1998: Martin Herrmann; Reinhard E Voll; O M Zoller; M Hagenhofer; BB Ponner; Joachim R Kalden
Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus.
Arthritis and rheumatism 1998;41(7):1241-50.
1998: Karin Manger; Roland Repp; Bernd M Spriewald; Astrid Rascu; A Geiger; Ralf Wassmuth; N A C Westerdaal; B Wentz; Bernhard Manger; Joachim R Kalden; Jan G J van de Winkel
Fcgamma receptor IIa polymorphism in Caucasian patients with systemic lupus erythematosus: association with clinical symptoms.
Arthritis and rheumatism 1998;41(7):1181-9.
1998: Joachim R Kalden; Thomas Geiler; Martin Herrmann; Wolf M Bertling
[Gene therapy in rheumatoid arthritis--an already feasible therapeutic principle?].
Zeitschrift für Rheumatologie 1998;57(3):139-46.
1998: Joachim R Kalden; Bernhard Manger
Biologic agents in the treatment of inflammatory rheumatic diseases.
Current opinion in rheumatology 1998;10(3):174-8.
1998: BB Ponner; Christian Stach; O Zoller; M Hagenhofer; Reinhard E Voll; Joachim R Kalden; Martin Herrmann
Induction of apoptosis reduces immunogenicity of human T-cell lines in mice.
Scandinavian journal of immunology 1998;47(4):343-7.
1998: Saifeddin Alsalameh; Bernhard Manger; P Kern; Joachim R Kalden
New onset of rheumatoid arthritis during interferon beta-1B treatment in a patient with multiple sclerosis: comment on the case report by Jabaily and Thompson.
Arthritis and rheumatism 1998;41(4):754.
1998: Renate Burger; Frank Neipel; Bernhard Fleckenstein; Rocco Savino; Gennaro Ciliberto; Joachim R Kalden; Martin Gramatzki
Human herpesvirus type 8 interleukin-6 homologue is functionally active on human myeloma cells.
Blood 1998;91(6):1858-63.
1998: M Hagenhofer; H Germaier; Christine Hohenadl; Peter Rohwer; Joachim R Kalden; Martin Herrmann
UV-B irradiated cell lines execute programmed cell death in various forms.
Apoptosis : an international journal on programmed cell death 1998;3(2):123-32.
1998: S Schulte; C Unger; J A Mo; Olaf Wendler; E Bauer; S Frischholz; Klaus von der Mark; Joachim R Kalden; Rikard Holmdahl; Harald Burkhardt
Arthritis-related B cell epitopes in collagen II are conformation-dependent and sterically privileged in accessible sites of cartilage collagen fibrils.
The Journal of biological chemistry 1998;273(3):1551-61.
1998: Vera Mahler; Christian Antoni; Grant J Anhalt; H J Koch; KP Peters; Bernhard Manger; Joachim R Kalden; OP Hornstein
Graft-versus-host-like mucocutaneous eruptions with serological features of paraneoplastic pemphigus and systemic lupus erythematosus in a patient with non-Hodgkin's lymphoma.
Dermatology (Basel, Switzerland) 1998;197(1):78-83.
1997: Hans G Kraetsch; Astrid Rascu; Joachim R Kalden; Bernhard Manger
[Clinical course and prognostic parameters in adult-onset Still's syndrome. Own experience and review of the literature].
Medizinische Klinik (Munich, Germany : 1983) 1997;92(12):705-11.
1997: Reinhard E Voll; E A Roth; Irute Girkontaite; H Fehr; Martin Herrmann; Hanns-Martin Lorenz; Joachim R Kalden
Histone-specific Th0 and Th1 clones derived from systemic lupus erythematosus patients induce double-stranded DNA antibody production.
Arthritis and rheumatism 1997;40(12):2162-71.
1997: Thomas Valerius; Bernhard Stockmeyer; Annemiek van Spriel; Robert F Graziano; IE van den Herik-Oudijk; Roland Repp; YM Deo; J Lund; Joachim R Kalden; Martin Gramatzki; Jan G J van de Winkel
FcalphaRI (CD89) as a novel trigger molecule for bispecific antibody therapy.
Blood 1997;90(11):4485-92.
1997: Reinhard E Voll; Martin Herrmann; E A Roth; Christian Stach; Joachim R Kalden; Irute Girkontaite
Immunosuppressive effects of apoptotic cells.
Nature 1997;390(6658):350-1.
1997: Thomas Valerius; D Würflein; Bernhard Stockmeyer; Roland Repp; Joachim R Kalden; Martin Gramatzki
Activated neutrophils as effector cells for bispecific antibodies.
Cancer immunology, immunotherapy : CII 1997;45(3-4):142-5.
1997: Mathias Grunke; Thomas Valerius; B Manger; Joachim R Kalden; Thomas Harrer
Renal dysfunction in a human immunodeficiency virus-infected patient who was treated with indinavir.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1997;25(5):1270-1.
1997: PM Cook; Thomas F Schulz; Astrid Rascu; Joachim R Kalden; Thomas Harrer
Lack of serologic evidence for involvement of human herpesvirus 8 in autoimmune diseases.
Arthritis and rheumatism 1997;40(10):1906-7.
1997: Eng M Tan; T E Feltkamp; Josef S Smolen; BT Butcher; R Dawkins; Marvin Fritzler; T Gordon; John Hardin; Joachim R Kalden; Robert G Lahita; Ravinder N Maini; J S McDougal; Naomi F Rothfield; RJ Smeenk; Y Takasaki; Allan Wiik; M R Wilson; J A Koziol
Range of antinuclear antibodies in "healthy" individuals.
Arthritis and rheumatism 1997;40(9):1601-11.
1997: R C Zollner; P Kern; H Steininger; Joachim R Kalden; Bernhard Manger
[Hyperferritinemia in Still syndrome in the adult and reactive hemophagocytic syndrome].
Medizinische Klinik (Munich, Germany : 1983) 1997;92(8):494-8.
1997: Peter Löw; C Weber; Ellen G Harrer; Peter Rohwer; Joachim R Kalden; Thomas Harrer
CD80 expression on monocytes in HIV-infected patients.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1997;15(4):264-8.
1997: Thomas Geiler; Hanns-Martin Lorenz; Joachim R Kalden; Bernhard Manger
[Pathogenesis of rheumatoid arthritis].
Medizinische Klinik (Munich, Germany : 1983) 1997;92(6):347-53.
1997: Hanns-Martin Lorenz; Thomas Geiler; Joachim R Kalden
[Immunosuppressive therapeutic modalities in chronic polyarthritis].
Der Internist 1997;38(6):532-40.
1997: Hanns-Martin Lorenz; Thomas Hieronymus; Mathias Grünke; Bernhard Manger; Joachim R Kalden
Differential role for IL-2 and IL-15 in the inhibition of apoptosis in short-term activated human lymphocytes.
Scandinavian journal of immunology 1997;45(6):660-9.
1997: Harald Burkhardt; P Meyer; Eberhard Buchner; Ernesta Palombo-Kinne; R Heinzel-Wieland; Wolfgang Becker; F Wolf; Joachim R Kalden; Raimund W Kinne
The serine proteinase inhibitor antileukoproteinase specifically accumulates in normal but not in arthritic cartilage.
The Journal of rheumatology 1997;24(6):1145-54.
1997: Joachim R Kalden
Rescue of DMARD failures by means of monoclonal antibodies or biological agents.
Clinical and experimental rheumatology 1997;15 Suppl 17():S91-8.
1997: Joachim R Kalden; Bernhard Manger
Biologic agents in the treatment of inflammatory rheumatic diseases.
Current opinion in rheumatology 1997;9(3):206-12.
1997: Astrid Rascu; Roland Repp; N A C Westerdaal; Joachim R Kalden; Jan G J van de Winkel
Clinical relevance of Fc gamma receptor polymorphisms.
Annals of the New York Academy of Sciences 1997;815():282-95.
1997: Bernhard Manger; Joachim R Kalden
[Mediastinal spreading and aortic insufficiency].
Medizinische Klinik (Munich, Germany : 1983) 1997;92(3):144.
1997: Josef S Smolen; BT Butcher; Marvin Fritzler; T Gordon; John Hardin; Joachim R Kalden; Robert G Lahita; Ravinder N Maini; Westley Reeves; M Reichlin; Naomi F Rothfield; Y Takasaki; Walther J van Venrooij; Eng M Tan
Reference sera for antinuclear antibodies. II. Further definition of antibody specificities in international antinuclear antibody reference sera by immunofluorescence and western blotting.
Arthritis and rheumatism 1997;40(3):413-8.
1997: Bernhard Stockmeyer; Thomas Valerius; Roland Repp; IA Heijnen; H J Bühring; YM Deo; Joachim R Kalden; Martin Gramatzki; Jan G J van de Winkel
Preclinical studies with Fc(gamma)R bispecific antibodies and granulocyte colony-stimulating factor-primed neutrophils as effector cells against HER-2/neu overexpressing breast cancer.
Cancer research 1997;57(4):696-701.
1997: Ulf Wagner; Sylke Kaltenhäuser; H Sauer; Sybille Arnold; Wolfram Seidel; Holm Häntzschel; Joachim R Kalden; R Wassmuth
HLA markers and prediction of clinical course and outcome in rheumatoid arthritis.
Arthritis and rheumatism 1997;40(2):341-51.
1997: Hanns-Martin Lorenz; Mathias Grünke; Thomas Hieronymus; Martin Herrmann; A Kühnel; Bernhard Manger; Joachim R Kalden
In vitro apoptosis and expression of apoptosis-related molecules in lymphocytes from patients with systemic lupus erythematosus and other autoimmune diseases.
Arthritis and rheumatism 1997;40(2):306-17.
1997: Wasilis Kolowos; Martin Herrmann; BB Ponner; Reinhard E Voll; P Kern; C Frank; Joachim R Kalden
Detection of restricted junctional diversity of peripheral T cells in SLE patients by spectratyping.
Lupus 1997;6(9):701-7.
1997: H Burkhardt; Joachim R Kalden
Animal models of autoimmune diseases.
Rheumatology international 1997;17(3):91-9.
1997: H Burkhardt; Joachim R Kalden
Xenobiotic immunosuppressive agents: therapeutic effects in animal models of autoimmune diseases.
Rheumatology international 1997;17(3):85-90.
1997: Joachim R Kalden
Defective phagocytosis of apoptotic cells: possible explanation for the induction of autoantibodies in SLE.
Lupus 1997;6(3):326-7.
1997: S Meusser; G Eger; M Anders; H Burkhardt; Joachim R Kalden
[Manifestation of neuro-Behçet disease in cyclosporin A therapy].
Zeitschrift für Rheumatologie 1997;56(1):31-9.
1997: Dolores Kalden-Nemeth; J Grebmeier; Christian Antoni; Bernhard Manger; F Wolf; Joachim R Kalden
NMR monitoring of rheumatoid arthritis patients receiving anti-TNF-alpha monoclonal antibody therapy.
Rheumatology international 1997;16(6):249-55.
1996: Sandra Reichstetter; G Brünnler; Joachim R Kalden; Ralf Wassmuth
DQB1 promoter sequence variability and linkage in caucasoids.
Human immunology 1996;51(2):73-80.
1996: W Baum; H Steininger; HJ Bair; Wolfgang Becker; T E Hansen-Hagge; Michael Kressel; Elisabeth Kremmer; Joachim R Kalden; Martin Gramatzki
Therapy with CD7 monoclonal antibody TH-69 is highly effective for xenografted human T-cell ALL.
British journal of haematology 1996;95(2):327-38.
1996: Martin Herrmann; Reinhard E Voll; W Woith; M Hagenhofer; Hanns-Martin Lorenz; Bernhard Manger; Joachim R Kalden
Small DNA fragments isolated from human T-cell clones are enriched in sequences involved in DNA bending.
Cell death and differentiation 1996;3(4):391-5.
1996: N A Hain; B Stuhlmüller; G R Hahn; Joachim R Kalden; R Deutzmann; Gerd R Burmester
Biochemical characterization and microsequencing of a 205-kDa synovial protein stimulatory for T cells and reactive with rheumatoid factor containing sera.
Journal of immunology (Baltimore, Md. : 1950) 1996;157(4):1773-80.
1996: Martin Herrmann; M Hagenhofer; Joachim R Kalden
Retroviruses and systemic lupus erythematosus.
Immunological reviews 1996;152():145-56.
1996: Astrid Rascu; Karin Manger; Hans G Kraetsch; Joachim R Kalden; Bernhard Manger
Osteonecrosis in systemic lupus erythematosus, steroid-induced or a lupus-dependent manifestation?
Lupus 1996;5(4):323-7.
1996: Karin Manger; Joachim R Kalden; Bernhard Manger
Cyclosporin A in the treatment of systemic lupus erythematosus: results of an open clinical study.
British journal of rheumatology 1996;35(7):669-75.
1996: Joachim R Kalden; Bernhard Manger
Biologic agents in the treatment of inflammatory rheumatic diseases.
Current opinion in rheumatology 1996;8(3):195-200.
1996: K R Aupperle; Saifeddin Alsalameh; K P Stock; Gerd R Burmester; Joachim R Kalden
[Comparison of rheumatoid test procedures--value and critical interpretation of sensitivity and specificity and their effect on pre-test and post-test probability].
Zeitschrift für Rheumatologie 1996;55(3):158-67.
1996: D Elsässer; Thomas Valerius; Roland Repp; G J Weiner; YM Deo; Joachim R Kalden; Jan G J van de Winkel; George T Stevenson; Martin J Glennie; Martin Gramatzki
HLA class II as potential target antigen on malignant B cells for therapy with bispecific antibodies in combination with granulocyte colony-stimulating factor.
Blood 1996;87(9):3803-12.
1996: H G Nüsslein; Karl-Heinz Frosch; W Woith; P Lane; Joachim R Kalden; Bernhard Manger
Increase of intracellular calcium is the essential signal for the expression of CD40 ligand.
European journal of immunology 1996;26(4):846-50.
1996: Hanns-Martin Lorenz; Christian Antoni; Thomas Valerius; Roland Repp; Mathias Grünke; N Schwerdtner; H Nüsslein; J Woody; Joachim R Kalden; Bernhard Manger
In vivo blockade of TNF-alpha by intravenous infusion of a chimeric monoclonal TNF-alpha antibody in patients with rheumatoid arthritis. Short term cellular and molecular effects.
Journal of immunology (Baltimore, Md. : 1950) 1996;156(4):1646-53.
1996: Martin Herrmann; O M Zoller; M Hagenhofer; Reinhard E Voll; Joachim R Kalden
What triggers anti-dsDNA antibodies?
Molecular biology reports 1996;23(3-4):265-7.
1996: S Meusser; A Rubbert; Bernhard Manger; E Bock; Günther Platsch; H Feistel; Andreas Engelhardt; F Wolf; Joachim R Kalden
99m-Tc-HMPAO-SPECT in diagnosis of early cerebral vasculitis.
Rheumatology international 1996;16(1):37-42.
1995: W S Becker; T M Behr; F Cumme; W Rössler; Jörg Wendler; P M Kern; Martin Gramatzki; Joachim R Kalden; David M Goldenberg; F G Wolf
67Ga citrate versus 99mTc-labeled LL2-Fab' (anti-CD22) fragments in the staging of B-cell non-Hodgkin's lymphoma.
Cancer research 1995;55(23 Suppl):5771s-5773s.
1995: S Meusser; R Beck; Bernhard Fleckenstein; Joachim R Kalden
[25-year-old patient with pancytopenia].
Der Internist 1995;36(10):999-1004.
1995: Martin Herrmann; T H Winkler; H Fehr; Joachim R Kalden
Preferential recognition of specific DNA motifs by anti-double-stranded DNA autoantibodies.
European journal of immunology 1995;25(7):1897-904.
1995: Bernhard Manger; Joachim R Kalden
Joint and connective tissue ultrasonography--a rheumatologic bedside procedure? A German experience.
Arthritis and rheumatism 1995;38(6):736-42.
1995: Joachim R Kalden; Bernhard Manger
Biologic agents in the treatment of inflammatory rheumatic diseases.
Current opinion in rheumatology 1995;7(3):191-7.
1994: Martin Herrmann; Hanns-Martin Lorenz; Reinhard E Voll; Mathias Grünke; W Woith; Joachim R Kalden
A rapid and simple method for the isolation of apoptotic DNA fragments.
Nucleic acids research 1994;22(24):5506-7.
1994: A Rubbert; E Bock; J Schwab; J Marienhagen; H Nüsslein; F Wolf; Joachim R Kalden
Anticardiolipin antibodies in HIV infection: association with cerebral perfusion defects as detected by 99mTc-HMPAO SPECT.
Clinical and experimental immunology 1994;98(3):361-8.
1994: F H Klebl; G Weber; Joachim R Kalden; H G Nüsslein
In vitro and in vivo effect of glucocorticoids on IgE and IgG subclass secretion.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 1994;24(11):1022-9.
1994: Joachim R Kalden
Anti-CD4 treatment of patients with rheumatoid arthritis. Is there still a place for this treatment principle in RA?
Clinical and experimental rheumatology 1994;12 Suppl 11():S67-9.
1994: Joachim R Kalden; S Gay
Retroviruses and autoimmune rheumatic diseases.
Clinical and experimental immunology 1994;98(1):1-5.
1994: R Burger; Jörg Wendler; K Antoni; G Helm; Joachim R Kalden; Martin Gramatzki
Interleukin-6 production in B-cell neoplasias and Castleman's disease: evidence for an additional paracrine loop.
Annals of hematology 1994;69(1):25-31.
1994: Saifeddin Alsalameh; Gary S Firestein; S Oez; R Kurrle; Joachim R Kalden; Gerd R Burmester
Regulation of granulocyte macrophage colony stimulating factor production by human articular chondrocytes. Induction by both tumor necrosis factor-alpha and interleukin 1, downregulation by transforming growth factor beta and upregulation by fibroblast growth factor.
The Journal of rheumatology 1994;21(6):993-1002.
1994: H G Nüsslein; G Weber; Joachim R Kalden
Synthetic glucocorticoids potentiate IgE synthesis. Influence of steroid and nonsteroid hormones on human in vitro IgE secretion.
Allergy 1994;49(5):365-70.
1994: Joachim R Kalden
Biologic agents in the therapy of inflammatory rheumatic diseases, including therapeutic antibodies, cytokines, and cytokine antagonists.
Current opinion in rheumatology 1994;6(3):281-6.
1994: U Keyna; E Platzer; W Woith; I Nüsslein; Joachim R Kalden; Bernhard Manger
Differential effects of transferrin receptor antibodies on growth and receptor expression of human lymphocytic and myelocytic cell lines.
European journal of haematology 1994;52(3):169-75.
1994: Martin Herrmann; Joachim R Kalden
PCR and reverse dot hybridization for the detection of endogenous retroviral transcripts.
Journal of virological methods 1994;46(3):333-48.
1994: B Stuhlmüller; I Kalies; H Kachelries; Katrin Druschky; Joachim R Kalden
Characterization of a 58- and a 78-kD monocytic membrane protein with affinity to the acetylcholine receptor in myasthenia gravis patients.
Scandinavian journal of immunology 1994;39(3):305-13.
1994: Sandra Reichstetter; P H Krellner; C M Meenzen; Joachim R Kalden; Ralf Wassmuth
Comparative analysis of sequence variability in the upstream regulatory region of the HLA-DQB1 gene.
Immunogenetics 1994;39(3):207-12.
1994: K Pirner; Astrid Rascu; W Nürnberg; A Rubbert; Joachim R Kalden; Bernhard Manger
Evidence for direct anti-heparin-sulphate reactivity in sera of SLE patients.
Rheumatology international 1994;14(4):169-74.
1994: Saifeddin Alsalameh; Gerd R Burmester; Joachim R Kalden
Basic mechanisms in rheumatoid arthritis: the role of T lymphocytes in rheumatoid synovitis.
Advances in prostaglandin, thromboxane, and leukotriene research 1994;22():289-304.
1993: H G Nüsslein; A Dietz; R Burger; T Träg; Joachim R Kalden; M Gramatzki
Chronic lymphocytic leukemia cells induce non-T cells to produce IgE in the presence of interleukin-4.
Journal of clinical immunology 1993;13(6):397-405.
1993: T Häupl; G Hahn; Michael G Rittig; A Krause; Christoph Schoerner; Ulrich Schönherr; Joachim R Kalden; Gerd R Burmester
Persistence of Borrelia burgdorferi in ligamentous tissue from a patient with chronic Lyme borreliosis.
Arthritis and rheumatism 1993;36(11):1621-6.
1993: T Nagel; G Eger; Joachim R Kalden; Bernhard Manger
[Arthroosteitis pustulosa, spondarthritis hyperostotica pustulo-psoriatica, SAPHO syndrome: clinical experiences and review of the literature].
Zeitschrift für Rheumatologie 1993;52(6):390-7.
1993: Ralf Wassmuth; S Eastman; Ingrid Kockum; E Holmberg; M Starck; T Lindhagen; Joachim R Kalden; Ake Lernmark; Göran Sundkvist; Stefan Lindgren
HLA DR and DQ RFLP analysis in Crohn's disease.
European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics 1993;20(5):429-33.
1993: B Stuhlmüller; Joachim R Kalden; Rudolf Fahlbusch; N Hain; Bernhard Manger
Immunological and functional properties of the acetylcholine receptor expressed on the human cell line TE671.
European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies 1993;31(10):657-65.
1993: A Rubbert; J Marienhagen; K Pirner; Bernhard Manger; J Grebmeier; Andreas Engelhardt; F Wolf; Joachim R Kalden
Single-photon-emission computed tomography analysis of cerebral blood flow in the evaluation of central nervous system involvement in patients with systemic lupus erythematosus.
Arthritis and rheumatism 1993;36(9):1253-62.
1993: Saifeddin Alsalameh; Juergen Mollenhauer; F Scheuplein; H Stöss; Joachim R Kalden; Harald Burkhardt; Gerd R Burmester
Preferential cellular and humoral immune reactivities to native and denatured collagen types IX and XI in a patient with fatal relapsing polychondritis.
The Journal of rheumatology 1993;20(8):1419-24.
1993: Thomas Valerius; Roland Repp; T P de Wit; S Berthold; E Platzer; Joachim R Kalden; Martin Gramatzki; Jan G J van de Winkel
Involvement of the high-affinity receptor for IgG (Fc gamma RI; CD64) in enhanced tumor cell cytotoxicity of neutrophils during granulocyte colony-stimulating factor therapy.
Blood 1993;82(3):931-9.
1993: W Woith; I Nüsslein; Christian Antoni; D I Dejica; T H Winkler; Martin Herrmann; K Pirner; Joachim R Kalden; Bernhard Manger
A soluble form of the human transferrin receptor is released by activated lymphocytes in vitro.
Clinical and experimental immunology 1993;92(3):537-42.
1993: K Pirner; A Rubbert; Gerd R Burmester; Joachim R Kalden; Bernhard Manger
[Intravenous administration of immunoglobulins in systemic lupus erythematosus: review of the literature and initial clinical experiences].
Infusionstherapie und Transfusionsmedizin 1993;20 Suppl 1():131-5; discussion 136.
1993: G Strobel; R Schwarz; P Heppt; B Granz; Joachim R Kalden; Bernhard Manger
[Use of an improved transmission ultrasound camera for diagnosis of rheumatic joint diseases].
Zeitschrift für Rheumatologie 1993;52(2):114-20.
1993: G Hahn; B Stuhlmüller; N Hain; Joachim R Kalden; K Pfizenmaier; Gerd R Burmester
Modulation of monocyte activation in patients with rheumatoid arthritis by leukapheresis therapy.
The Journal of clinical investigation 1993;91(3):862-70.
1993: H M Lorenz; Thomas Harrer; A S Lagoo; A Baur; G Eger; Joachim R Kalden
CD45 mAb induces cell adhesion in peripheral blood mononuclear cells via lymphocyte function-associated antigen-1 (LFA-1) and intercellular cell adhesion molecule 1 (ICAM-1).
Cellular immunology 1993;147(1):110-28.
1993: Gerd Horneff; Ulrich Sack; Joachim R Kalden; Frank Emmrich; Gerd R Burmester
Reduction of monocyte-macrophage activation markers upon anti-CD4 treatment. Decreased levels of IL-1, IL-6, neopterin and soluble CD14 in patients with rheumatoid arthritis.
Clinical and experimental immunology 1993;91(2):207-13.
1993: Gerd Horneff; Andreas H Guse; H Schulze-Koops; Joachim R Kalden; Gerd R Burmester; Frank Emmrich
Human CD4 modulation in vivo induced by antibody treatment.
Clinical immunology and immunopathology 1993;66(1):80-90.
1993: Joachim R Kalden; Martin Herrmann
Autoimmune diseases in humans, e.g. autoimmune rheumatic diseases.
Intervirology 1993;35(1-4):176-85.
1993: Lecy Tschirner; T H Winkler; H K Fehr; Ekkehard K F Bautz; Joachim R Kalden
A new approach to the molecular characterization of the c-ANCA antigen in Wegener's granulomatosis.
Advances in experimental medicine and biology 1993;336():51-4.
1993: E Pedrollo; Lecy Tschirner; F A Bautz; Joachim R Kalden; Ekkehard K F Bautz
Antineutrophil cytoplasmic autoantibodies (ANCA) recognizing a recombinant myeloperoxidase subunit.
Advances in experimental medicine and biology 1993;336():87-92.
1992: Gerd Horneff; Frank Emmrich; C Reiter; Joachim R Kalden; Gerd R Burmester
Persistent depletion of CD4+ T cells and inversion of the CD4/CD8 T cell ratio induced by anti-CD4 therapy.
The Journal of rheumatology 1992;19(12):1845-50.
1992: H G Nüsslein; T Träg; M Winter; A Dietz; Joachim R Kalden
The role of T cells and the effect of hydrocortisone on interleukin-4-induced IgE synthesis by non-T cells.
Clinical and experimental immunology 1992;90(2):286-92.
1992: Frank Emmrich; Gerd R Burmester; Gerd Horneff; J Emmrich; P Reinke; F Hiepe; Joachim R Kalden; H Schulze-Koops; H D Volk
[Treatment of autoimmune diseases and graft rejection with anti-CD4 antibodies].
Zeitschrift für die gesamte innere Medizin und ihre Grenzgebiete 1992;47(11):500-7.
1992: A Rubbert; K Pirner; L Wildt; Joachim R Kalden; Bernhard Manger
Pregnancy course and complications in patients with systemic lupus erythematosus.
American journal of reproductive immunology (New York, N.Y. : 1989) 1992;28(3-4):205-7.
1992: Joachim R Kalden
WHO/IUIS Standardization Programme.
Clinical and experimental rheumatology 1992;10(5):513-4.
1992: Thomas Harrer; B Wolf; W Näger; W Schwarz; D Bergner; Joachim R Kalden
In vitro activation of peripheral mononuclear cells by zinc in HIV-infected patients and healthy controls.
Clinical and experimental immunology 1992;89(2):285-9.
1992: T H Winkler; H Fehr; Joachim R Kalden
Analysis of immunoglobulin variable region genes from human IgG anti-DNA hybridomas.
European journal of immunology 1992;22(7):1719-28.
1992: Wolfgang Becker; Gerd Horneff; Frank Emmrich; Gerd R Burmester; Joachim R Kalden; F Wolf
Kinetics of 99mTc-labelled antibodies against CD4 (T-helper) lymphocytes in man.
Nuklearmedizin. Nuclear medicine 1992;31(3):84-90.
1992: Joachim R Kalden
Pathogenic aspects of systemic lupus erythematosus (SLE).
Behring Institute Mitteilungen 1992;(91):197-203.
1992: A Rubbert; K Pirner; L Wildt; Joachim R Kalden; Bernhard Manger
[Systemic lupus erythematosus and pregnancy].
Zeitschrift für Rheumatologie 1992;51(2):78-86.
1992: K Pirner; A Rubbert; R Salinger; Joachim R Kalden; Bernhard Manger
[Significance of ultraviolet light in the pathogenesis of systemic lupus erythematosus: case report and discussion of the literature].
Zeitschrift für Rheumatologie 1992;51(1):20-4.
1992: Martin Herrmann; A Baur; H Nebel-Schickel; R Vornhagen; Gerhard Jahn; F E Krapf; Joachim R Kalden
Antibodies against p24 of HIV-1 in patients with systemic lupus erythematosus?
Viral immunology 1992;5(3):229-31.
1991: Saifeddin Alsalameh; Joachim R Kalden; Gerd R Burmester
[The role of cytokines and growth factors in rheumatoid joint destruction].
Zeitschrift für Rheumatologie 1991;50(6):347-59.
1991: A Baur; Thomas Harrer; M Peukert; Gerhard Jahn; Joachim R Kalden; Bernhard Fleckenstein
Alpha-lipoic acid is an effective inhibitor of human immuno-deficiency virus (HIV-1) replication.
Klinische Wochenschrift 1991;69(15):722-4.
1991: T H Winkler; S Jahn; Joachim R Kalden
IgG human monoclonal anti-DNA autoantibodies from patients with systemic lupus erythematosus.
Clinical and experimental immunology 1991;85(3):379-85.
1991: Joachim R Kalden; F Krapf
[Plasma nucleic acids and their possible pathophysiologic significance in systemic lupus erythematosus].
Zeitschrift für Rheumatologie 1991;50(5):297-303.
1991: A Rubbert; Bernhard Manger; N Lang; Joachim R Kalden; E Platzer
Functional characterization of tumor-infiltrating lymphocytes, lymph-node lymphocytes and peripheral-blood lymphocytes from patients with breast cancer.
International journal of cancer. Journal international du cancer 1991;49(1):25-31.
1991: Roland Repp; Thomas Valerius; A Sendler; Martin Gramatzki; Heinrich Iro; Joachim R Kalden; E Platzer
Neutrophils express the high affinity receptor for IgG (Fc gamma RI, CD64) after in vivo application of recombinant human granulocyte colony-stimulating factor.
Blood 1991;78(4):885-9.
1991: Lecy Tschirner; Bernhard Manger; T H Winkler; M Herrman; Gerd R Burmester; F E Krapf; Joachim R Kalden
The role of antineutrophil cytoplasm antibodies, anticardiolipin antibodies, von Willebrand factor antigen, and fibronectin for the diagnosis of systemic vasculitis.
The Journal of rheumatology 1991;18(8):1199-206.
1991: Martin Gramatzki; R Burger; J Kraus; U Lauer; Peter Rohwer; G Eger; Joachim R Kalden; F Henschke
Monoclonal antibodies EBU-141 (CDw75) and EBU-65 allow reliable distinction between mature and pre-B-cell tumors in suspension and on tissue sections.
Annals of hematology 1991;63(1):20-6.
1991: J G Scheuerlein; I Kalies; W P Gluth; Joachim R Kalden
Monoclonal antibodies monospecific to single-chain urokinase-type plasminogen activator (scu-PA).
Hybridoma 1991;10(3):395-9.
1991: Gerd Horneff; T Winkler; Joachim R Kalden; Frank Emmrich; Gerd R Burmester
Human anti-mouse antibody response induced by anti-CD4 monoclonal antibody therapy in patients with rheumatoid arthritis.
Clinical immunology and immunopathology 1991;59(1):89-103.
1991: A Krause; V Brade; Christoph Schoerner; W Solbach; Joachim R Kalden; Gerd R Burmester
T cell proliferation induced by Borrelia burgdorferi in patients with Lyme borreliosis. Autologous serum required for optimum stimulation.
Arthritis and rheumatism 1991;34(4):393-402.
1991: Gerd Horneff; Frank Emmrich; Joachim R Kalden; Gerd R Burmester
[Suppression of monocyte-macrophage activation by anti-CD4 therapy in patients with chronic polyarthritis].
Immunität und Infektion 1991;19(2):55-6.
1991: Gerd Horneff; Wolfgang Becker; F Wolf; Joachim R Kalden; Gerd R Burmester
[Human anti-murine immunoglobulin antibodies as disturbing factors in TSH determination].
Klinische Wochenschrift 1991;69(5):220-3.
1991: Saifeddin Alsalameh; B Jahn; A Krause; Joachim R Kalden; Gerd R Burmester
Antigenicity and accessory cell function of human articular chondrocytes.
The Journal of rheumatology 1991;18(3):414-21.
1991: A Krause; A Rensing; Joachim R Kalden; Gerd R Burmester
Cellular immune response to Borrelia burgdorferi in patients with Lyme borreliosis.
Behring Institute Mitteilungen 1991;(88):52-8.
1991: Gerd R Burmester; U Altstidl; Joachim R Kalden; Frank Emmrich
Stimulatory response towards the 65 kDa heat shock protein and other mycobacterial antigens in patients with rheumatoid arthritis.
The Journal of rheumatology 1991;18(2):171-6.
1991: Gerd Horneff; Gerd R Burmester; Frank Emmrich; Joachim R Kalden
Treatment of rheumatoid arthritis with an anti-CD4 monoclonal antibody.
Arthritis and rheumatism 1991;34(2):129-40.
1991: U Keyna; I Nüsslein; P Rohwer; Joachim R Kalden; Bernhard Manger
The role of the transferrin receptor for the activation of human lymphocytes.
Cellular immunology 1991;132(2):411-22.
1991: H G Nüsslein; M Winter; T Träg; Joachim R Kalden
Interleukin-4-induced IgG subclass and IgE secretion by mononuclear cells from atopic donors.
International archives of allergy and applied immunology 1991;95(2-3):257-60.
1991: Joachim R Kalden; T Winkler; F Krapf
Are retroviruses involved in the aetiology of rheumatic diseases?
British journal of rheumatology 1991;30 Suppl 1():63-9.
1991: Joachim R Kalden; T H Winkler; Martin Herrmann; F Krapf
Pathogenesis of SLE: immunopathology in man.
Rheumatology international 1991;11(3):95-100.
1990: S Oez; C Bührer; J Atzpodien; Joachim R Kalden
A highly sensitive quantitative bioassay for human granulocyte-macrophage colony-stimulating factor.
Experimental hematology 1990;18(10):1108-11.
1990: K Pirner; Wolf Rösler; Joachim R Kalden; Bernhard Manger
[Long-term remission after i.v. immunoglobulin therapy in acquired antihemophilic factor hemophilia with systemic lupus erythematosus].
Zeitschrift für Rheumatologie 1990;49(6):378-81.
1990: Thomas Valerius; Roland Repp; Joachim R Kalden; E Platzer
Effects of IFN on human eosinophils in comparison with other cytokines. A novel class of eosinophil activators with delayed onset of action.
Journal of immunology (Baltimore, Md. : 1950) 1990;145(9):2950-8.
1990: Saifeddin Alsalameh; Juergen Mollenhauer; N Hain; K P Stock; Joachim R Kalden; Gerd R Burmester
Cellular immune response toward human articular chondrocytes. T cell reactivities against chondrocyte and fibroblast membranes in destructive joint diseases.
Arthritis and rheumatism 1990;33(10):1477-86.
1990: Thomas Harrer; B Wolf; W Kersten; W Schwarz; D Bergner; Joachim R Kalden
[HIV-1 antigenemia and T-cell activation in HIV-1 infected patients].
Klinische Wochenschrift 1990;68(17):864-8.
1990: S Oez; H Tittelbach; R Fahsold; R Schaetzl; C Bührer; J Atzpodien; Joachim R Kalden
Establishment and characterization of a granulocyte-macrophage colony-stimulating factor-dependent human myeloid cell line.
Blood 1990;76(3):578-82.
1990: S Oez; Karl Welte; E Platzer; Joachim R Kalden
A simple assay for quantifying the inducible adherence of neutrophils.
Immunobiology 1990;180(4-5):308-15.
1990: F E Krapf; Martin Herrmann; W Leitmann; B Schwartländer; Joachim R Kalden
Circulating immune complexes in HIV-infected persons.
Klinische Wochenschrift 1990;68(6):299-305.
1990: Reinhard E Voll; C Aepinus; F Krapf; Martin Herrmann; Joachim R Kalden; Bernhard Fleckenstein
Monoclonal antibodies directed against the rev protein of human immunodeficiency virus type 1.
Molecular and cellular probes 1990;4(1):63-72.
1990: N Hain; Saifeddin Alsalameh; W M Bertling; Joachim R Kalden; Gerd R Burmester
Stimulation of rheumatoid synovial and blood T cells and lines by synovial fluid and interleukin-2: characterization of clones and recognition of a co-stimulatory effect.
Rheumatology international 1990;10(5):203-10.
1989: Thomas Harrer; K Messing; U Bienzle; E Meyer; J Giedl; Joachim R Kalden
[Manifestation of AIDS in HIV infected homosexual males with lymphadenopathy syndrome].
Klinische Wochenschrift 1989;67(18):936-9.
1989: B Koch; W Baum; Gerd R Burmester; Peter Rohwer; M Reinke; J Zacher; H Kirchner; Joachim R Kalden
[Prostaglandin E2, interleukin 1 and gamma interferon production of mononuclear cells of patients with inflammatory and degenerative joint diseases].
Zeitschrift für Rheumatologie 1989;48(4):194-9.
1989: F Krapf; Martin Herrmann; W Leitmann; Joachim R Kalden
Antibody binding of macromolecular DNA and RNA in the plasma of SLE patients.
Clinical and experimental immunology 1989;75(3):336-42.
1989: C Huber; A Rüger; Martin Herrmann; F Krapf; Joachim R Kalden
C3-containing serum immune complexes in patients with systemic lupus erythematosus: correlation to disease activity and comparison with other rheumatic diseases.
Rheumatology international 1989;9(2):59-64.
1989: Eckhard Schulze-Lohoff; F Krapf; Lecy Tschirner; Gerd R Burmester; K Kölble; H G Nüsslein; W Rödl; Joachim R Kalden
IGM-containing immune complexes and antiphospholipid antibodies in patients with Sneddon's syndrome.
Rheumatology international 1989;9(1):43-8.
1989: Gerd R Burmester; B Jahn; N Hain; G Strobel; Joachim R Kalden
T cell regulation and T cell clones in relation to synovial inflammation.
Springer seminars in immunopathology 1989;11(3):259-72.
1989: F E Krapf; Martin Herrmann; W Leitmann; Joachim R Kalden
Are retroviruses involved in the pathogenesis of SLE? Evidence demonstrated by molecular analysis of nucleic acids from SLE patients' plasma.
Rheumatology international 1989;9(3-5):115-21.
1989: T Häupl; Gerd R Burmester; G Hahn; Ulrich Feige; C Rordorf-Adam; Joachim R Kalden
Differential immunological response of patients with rheumatoid arthritis towards two different Epstein-Barr virus strains: inhibition of interleukin-1 release by the B95-8, but not the P3HR-1 virus strain.
Rheumatology international 1989;9(3-5):153-60.
1988: T H Winkler; T A Henschel; I Kalies; H W Baenkler; F Skvaril; Joachim R Kalden
Constant isotype pattern of anti-dsDNA antibodies in patients with systemic lupus erythematosus.
Clinical and experimental immunology 1988;72(3):434-9.
1988: Martin Gramatzki; Gerd R Burmester; H J König; F Henschke; Joachim R Kalden
Synovial fluid involvement in null cell acute lymphoblastic leukemia diagnosed with monoclonal antibodies.
The Journal of rheumatology 1988;15(3):500-4.
1988: C Fuchs; F Krapf; P Kern; S Hoferichter; W Jäger; Joachim R Kalden
CEA-containing immune complexes in sera of patients with colorectal and breast cancer--analysis of complexed immunoglobulin classes.
Cancer immunology, immunotherapy : CII 1988;26(2):180-4.
1988: N Hain; Gerd R Burmester; Joachim R Kalden
T cell clones in rheumatoid arthritis (RA).
Scandinavian journal of rheumatology. Supplement 1988;76():145-52.
1988: E Platzer; S Simon; Joachim R Kalden
Human granulocyte colony stimulating factor: effects on human long-term bone marrow cultures.
Blood cells 1988;14(2-3):463-9.
1987: B Jahn; Gerd R Burmester; P Stock; Peter Rohwer; Joachim R Kalden
Functional and phenotypical characterization of activated T cells from intra-articular sites in inflammatory joint diseases. Possible modulation of the CD3 antigen.
Scandinavian journal of immunology 1987;26(6):745-54.
1987: P A Göhring; Gerd R Burmester; Joachim R Kalden
Adhesion of human T lymphocytes to endothelial cells isolated from the umbilical vein: I. Similar binding patterns of normal and rheumatoid T cells.
Immunobiology 1987;175(5):385-93.
1987: Gerd R Burmester; G F Strobel; P Göhring; Joachim R Kalden
Adhesion of human T lymphocytes to endothelial cells isolated from the umbilical vein: II. Enhanced binding of in vitro activated T lymphocytes.
Immunobiology 1987;175(5):394-405.
1987: Thomas Harrer; K Messing; U Bienzle; E Meyer; J Giedl; Joachim R Kalden
[Follow-up in HIV-infected homosexual males with lymphadenopathy syndrome].
Klinische Wochenschrift 1987;65(18):864-72.
1987: Gerd R Burmester; B Jahn; Peter Rohwer; J Zacher; R J Winchester; Joachim R Kalden
Differential expression of Ia antigens by rheumatoid synovial lining cells.
The Journal of clinical investigation 1987;80(3):595-604.
1987: Joachim R Kalden
[Cytokines in tumor therapy].
Onkologie 1987;10(4):240-4.
1987: H G Nüsslein; T Zimmermann; M Baum; C Fuchs; K Kölble; Joachim R Kalden
Improved in vitro diagnosis of allergy to Alternaria tenius and Cladosporium herbarum.
Allergy 1987;42(6):414-22.
1987: Joachim R Kalden
[Immunology of the gastrointestinal system].
Zeitschrift für Rheumatologie 1987;46 Suppl 1():10-3.
1987: B Jahn; Gerd R Burmester; H Schmid; G Weseloh; Peter Rohwer; Joachim R Kalden
Changes in cell surface antigen expression on human articular chondrocytes induced by gamma-interferon. Induction of Ia antigens.
Arthritis and rheumatism 1987;30(1):64-74.
1986: F Krapf; C Fuchs; Martin Herrmann; S Hoferichter; Joachim R Kalden
Determination of complement activating circulating immune complexes and an example for antigen specific immune complex assays.
Journal of clinical & laboratory immunology 1986;21(4):183-7.
1986: E Platzer; S Oez; Karl Welte; A Sendler; J L Gabrilove; R Mertelsmann; Malcolm A S Moore; Joachim R Kalden
Human pluripotent hemopoietic colony stimulating factor: activities on human and murine cells.
Immunobiology 1986;172(3-5):185-93.
1986: B Jahn; Gerd R Burmester; M Gramatzki; G Weseloh; P Stock; Joachim R Kalden
Intraarticular T lymphocytes in monoarticular and oligoarticular inflammatory joint diseases. Normal subset distribution and less numbers of activated T cells indicate major differences as compared to rheumatoid arthritis.
The Journal of rheumatology 1986;13(2):254-8.
1984: I Kalies; F Heinz; R Hohlfeld; H Wekerle; K L Birnberger; Joachim R Kalden
Physiochemical and immunological properties of acetylcholine receptors from human muscle.
Molecular and cellular biochemistry 1984;64(1):69-79.
1984: Gerd R Burmester; B Jahn; M Gramatzki; J Zacher; Joachim R Kalden
Activated T cells in vivo and in vitro: divergence in expression of Tac and Ia antigens in the nonblastoid small T cells of inflammation and normal T cells activated in vitro.
Journal of immunology (Baltimore, Md. : 1950) 1984;133(3):1230-4.
1984: M Gramatzki; W Baum; Gerd R Burmester; Joachim R Kalden
Preservation of the helper and suppressor/cytotoxic T-lymphocyte phenotype in continuous culture.
European journal of immunology 1984;14(8):762-5.
1984: I Kalies; F Heinz; W P Kaschka; Katrin Druschky; Joachim R Kalden
[Heterogeneity of acetylcholine receptor antibodies in patients with myasthenia gravis].
Klinische Wochenschrift 1984;62(8):377-85.
1984: Gerd R Burmester; J Schneeberger; B Jahn; M Gramatzki; J Zacher; Joachim R Kalden
Rheumatoid non-lymphoid synovial cells and the induction of mixed leukocyte reactions. Low-density preparations containing Ia+ macrophages and dendritic cells are less stimulatory than peripheral blood non-T cells.
Rheumatology international 1984;4 Suppl():31-7.
1981: R Hohlfeld; I Kalies; F Heinz; Joachim R Kalden; H Wekerle
Autoimmune rat T lymphocytes monospecific for acetylcholine receptors: purification and fine specificity.
Journal of immunology (Baltimore, Md. : 1950) 1981;126(4):1355-9.